Publikationen

Hier finden Sie ausgewählte Publikationen aus der Klinik für Dermatologie, Venerologie und Allergologie

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald R, Schartl M, Goebeler M, Meierjohann S (2019)
Identification of  patient-specific mutations reveals dual pathway activation in most melanoma patients and activated receptor tyrosine kinases in BRAF/NRAS wildtype melanomas.
Cancer 125, 586-600

Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M. Panel (2018)
Sequencing Reveals Recurrent Genetic FAS Alterations In Primary Cutaneous Marginal Zone Lymphoma.
J Invest Dermatol 138, 1573-1581 

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ (2018)
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell 173, 624-633.e8

Adam C, Wohlfarth J, Haußmann M, Sennefelder H, Rodin A, Maler M, Martin SF, Goebeler M, Schmidt M (2017)
Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation.
J Invest Dermatol 137, 367-376

Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E (2016)
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells.
Nat Commun 7, 11724

Publikationen 2021

Salviano-Silva A, Becker M, Augusto DG, Busch H, Adelman Cipolla G, Farias TDJ, Bumiller-Bini V, Calonga-Solís V, Munz M; Franke A, Wittig M, Camargo CM; Goebeler M, Hundt JE, Günther C, Gläser R, Hadaschik E, Pföhler C, Sárdy M, van Beek N, Worm M, Zillikens D, Boldt ABW, Schmidt E, Petzl-Erler ML, Ibrahim S, Malheiros D (2021)
Genetic association and differential expression of HLA Complex Group lncRNAs in pemphigus.
J Autoimmunity 123 (2021) 102705
Zur Publikation

Maron RC, Schlager JG, Haggenmüller S, von Kalle C, Utikal JS, Meier F, Gellrich FF, Hobelsberger S, Hauschild A, French L, Heinzerling L, Schlaak M, Ghoreschi K, Hilke FJ, Poch G, Heppt MV, Berking C, Haferkamp S, Sondermann W, Schadendorf D, Schilling B, Goebeler M, Krieghoff-Henning E, Hekler A, Fröhling S, Lipka DB, Kather JN, Brinker TJ (2021)
A Benchmark for Neural Network Robustness in Skin Cancer Classification.
Eur J Cancer 2021 155:191-199 
Zur Publikation

Frings VG, Schöffski O, Goebeler M, Presser D (2021)
Economic analysis of the costs associated with Hidradenitis suppurativa at a German University Hospital.
PLOS One (2021), 16(8)
Zur Publikation

Schubert S, Bauer A, Hillen U, Werfel T, Geier J, Brans R, IVDK (2021) 
Occupational contact dermatitis in painters and varnishers: data from the Information Network of Departments of Dermatology (IVDK), 2000 to 2019.
Contact Dermatitis. 2021 Jul 14. doi: 10.1111/cod.13935.
Zur Publikation

Filipski K, Scherer M, Zeiner KN, Bucher A, Kleemann J, Jurmeister P, Hartung TI, Meissner M, Plate KH, Fenton TR, Walter J, Tierling S, Schilling B, Zeiner PS, Harter PN (2021)
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma.
J Immunother Cancer. 2021 Jul;9(7)
Zur Publikation

Glutsch V, Kneitz H, Gesierich A, Goebeler M, Haferkamp S, Becker JC, Ugurel S, Schilling B (2021)
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.
Cancer Immunol Immunother. 2021 Jul;70(7):2087-2093. 
Zur Publikation

Hamm H, Wilsmann-Theis D, Tsianakas A, Gambichler T, Taipale K, Lauterbach J, Freudensprung U, Makepeace C and KIFUderm study investigators (2021)
Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate-to-severe plaque psoriasis - A randomised, double-blinded, placebo-controlled trial.
Br J Dermatol. 2021 Jul;185(1):62-73.
Zur Publikation

Zaremba A, Philip M, Hassel JC, Glutsch V, Fiocco Z, Loquai C, Rafei-Shamsabadi D, Gutzmer R, Utikal J, Haferkamp S, Reinhardt L, Kähler KC, Weishaupt C, Moreira A, Thoms KM, Wilhelm T, Pföhler C, Roesch A, Ugurel S, Zimmer L, Stadtler N, Sucker A, Kiecker F, Heinzerling L, Meier F, Meiss F, Schlaak M, Schilling B, Horn S, Schadendorf D, Livingstone E (2021)
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Eur J Cancer. 2021 Jun 5;152:139-154.
Zur Publikation

Wehkamp U, Mitteldorf C, Stendel S, Stranzenbach R, Nicolay JP, Wobser M, Weichenthal M, Schneiderbauer R, Klemke CD, Hillen U, Kempf W, Assaf C (2021)
Most rare subtypes of cutaneous lymphoma display variable CD30 expression. Analysis of the German Cutaneous Lymphoma Network.
Br J Dermatol. 2021 185, 228-230.
Zur Publikation

Höhn J, Hekler A, Krieghoff-Henning E, Kather JN, Utikal JS, Meier F, Gellrich FF, Hauschild A, French L, Schlager JG, Ghoreschi K, Wilhelm T, Kutzner H, Heppt M, Haferkamp S, Sondermann W, Schadendorf D, Schilling B, Maron RC, Schmitt M, Jutzi T, Fröhling S, Lipka DB, Brinker TJ (2021)
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.
J Med Internet Res. 2021 Jul 2;23(7):e20708.
Zur Publikation

Paudel R, Fusi L, Schmidt M (2021)
The MEK5/ERK5 pathway in health and disease.
Int J Mol Sci 
Zur Publikation

Ickrath F, Stoevesandt J, Schulmeyer L, Glatzel C, Goebeler M, Kerstan A (2021)
Metastatischer Morbus Crohn: eine unterschätzte Entität.
J Dtsch Dermatol Ges. 2021 19(7):973-982.
Zur Publikation

Ickrath F, Stoevesandt J, Schulmeyer L, Glatzel C, Goebeler M, Kerstan A (2021)
Metastatic Crohn's disease: an underestimated entity.
J Dtsch Dermatol Ges. 2021 July 19(7):973-982.
Zur Publikation

Kirsten N, Frings V, Nikolakis GD, Presser D, Goebeler M, Zouboulis CC, Augustin M (2021)
Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa.
Hautarzt. (2021) 72:651-657_doi: 10.1007/s00105-021-04851-z
Zur Publikation

Geier J, Schubert S, Schnuch A, Szliska C, Weisshaar E, Kränke B, Werfel T, Ruëff F, Schröder-Kraft C, Buhl T (2021)
Information Network of Departments of Dermatology. A negative breakdown test in a fragrance mix I-positive patient does not rule out contact allergy to its fragrance constituents.
Contact Dermatitis. 2021 Jun;84(6):407-418.
Zur Publikation

Wobser M, Roth S, Appenzeller S, Kneitz H, Goebeler M, Geissinger E, Rosenwald A, Maurus K (2021)
Oncogenic mutations and gene fusions in CD30-positive lymphoproliferations and clonally related mycosis fungoides occurring in the same patients.
JID Innovations (2021) 1:1000034_doi: 10.1016/j.xjidi.2021.100034. 
Zur Publikation

Thomann AS, Schneider T, Cyran L, Eckert IN, Kerstan A, Lutz MV (2021)
Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo.
Frontiers Immunol. 25 June 2021 doi: 10.3389/fimmu.2021.704578
Zur Publikation

Frings VG, Goebeler M, Schilling B, Kneitz H (2021)
Aberrant cytoplasmic connexin43 expression as a helpful marker in vascular neoplasms.
J Cutan Pathol. 2021 May 21.
Zur Publikation

Schwarm C, Gola D, Holtsche MM, Dieterich A, Bhandari A, Freitag M, Nürnberg P, Toliat M, Lieb W, Wittig M, Franke A, Worm M, Sticherling M, Ehrchen J, Günther C, Gläser R, Peitsch WK, Sárdy M, Eming R, Hertl M, Benoit S, Goebeler M, Pföhler C, Kunz M, Kreuter A, van Beek N, Erdmann J, Busch H, Zillikens D, Sadik CD, Hirose M, König IR, Schmidt E, Ibrahim SM; German AIBD Study Group (2021)
Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans. Orphanet
J Rare Dis. 2021 May 19;16(1):228. doi: 10.1186/s13023-021-01863-9
Zur Publikation

Dege T, Wobser M, Goebeler M, Reichel A (2021)
Pressure sensitive livid node on the left knee.
Hautarzt. 2021 May 3.
Zur Publikation

Höhn J, Krieghoff-Henning E, Jutzi TB, von Kalle C, Utikal JS, Meier F, Gellrich FF, Hobelsberger S, Hauschild A, Schlager JG, French L, Heinzerling L, Schlaak M, Ghoreschi K, Hilke FJ, Poch G, Kutzner H, Heppt MV, Haferkamp S, Sondermann W, Schadendorf D, Schilling B, Goebeler M, Hekler A, Fröhling S, Lipka DB, Kather JN, Krahl D, Ferrara G, Haggenmüller S, Brinker TJ (2021)
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification.
Eur J Cancer. 2021 May;149:94-101
Zur Publikation

Kähler KC, Gutzmer R, Meier F, Zimmer L, Heppt M, Gesierich A, Thoms KM, Utikal J, Hassel JC, Loquai C, Pföhler C, Heinzerling L, Kaatz M, Göppner D, Pflugfelder A, Bohne AS, Satzger I, Reinhardt L, Placke JM, Schadendorf D, Ugurel S (2021)
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study.
Front Oncol. 2021 May 24;11:672172.
Zur Publikation

Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, Hassel JC, Weishaupt C, Eigentler T, Schilling B, Schummer P, Sirokay J, Kiecker F, Owen CN, Fleischer MI, Cann C, Kähler KC, Mohr P, Bluhm L, Niebel D, Thoms KM, Goldinger SM, Reinhardt L, Meier F, Berking C, Reinhard R, Susok L, Ascierto PA, Drexler K, Pföhler C, Tietze J, Heinzerling L, Livingstone E, Ugurel S, Long GV, Stang A, Schadendorf D, Zimmer L (2021)
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Eur J Cancer. 2021 May;148:61-75
Zur Publikation

Versluis JM, Reijers ILM, Rozeman EA, Menzies AM, van Akkooi ACJ, Wouters MW, Ch'ng S, Saw RPM, Scolyer RA, van de Wiel BA, Schilling B, Long GV, Blank CU (2021)
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma.
Eur J Cancer. 2021 May;148:51-57.
Zur Publikation

Torres MJ, Trautmann A, Böhm I, Scherer K, Barbaud A, Bavbek S, Bonadonna P, Cernadas J, Chiriac A, Gaeta F, Gimenez-Arnau AM, Kang H, Moreno E, Brockow K (2021)
Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensitivity.
Allergy. 2021 May;76(5):1325-1339.
Zur Publikation 

Trubiano JA, Soria A, Torres MJ, Trautmann A (2021)
Treating Through of Drug-Associated Exanthem in Drug Allergy Management: Current Evidence and Clinical Aspects.
J Allergy Clin Immunol Pract. 2021 Apr 17:S2213-2198(21)00448-7. doi: 10.1016/j.jaip.2021.04.008. 
Zur Publikation

Boas PV, Frings V, Gran F, Lesort C, Machado Á, Arianayagam S (2021)
What's new?
Eur J Dermatol. 2021 Apr 1;31(2)
Zur Publikation

Heitmann J, Frings VG, Geier A, Goebeler M, Kerstan A (2021)
Nicht-alkoholische Fettlebererkrankung und Psoriasis - besteht ein gemeinsames proinflammatorisches Netzwerk?
J Dtsch Dermatol Ges. 2021 Apr;19(4):517-529.
Zur Publikation

Kadioglu O, Saeed MEM, Greten HJ, Mayr K, Schrama D, Roos WP, Efferth T (2021)
Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells.
J Am Acad Dermatol 2021 Apr;84(4):1086-1089
Zur Publikation

Stege HM, Haist M, Schultheis S, Fleischer MI, Mohr P, Ugurel S, Terheyden P, Thiem A, Kiecker F, Leiter U, Becker JC, Meissner M, Kleeman J, Pföhler C, Hassel J, Grabbe S, Loquai C (2021)
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.
Cancer Immunol Immunother. 2021 Apr 18. doi: 10.1007/s00262-021-02925-4
Zur Publikation

Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, Gesierich A, Weppler A, Spain L, Loquai C, Dudda M, Pföhler C, Hepner A, Long GV, Menzies AM, Carlino MS, Sachse MM, Lebbé C, Baroudjian B, Enokida T, Tahara M, Schlaak M, Hayani K, Bröckelmann PJ, Meier F, Reinhardt L, Friedlander P, Eigentler T, Kähler KC, Berking C, Zimmer L, Heinzerling L (2021)
Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Eur J Cancer. 2021 Apr;147:170-181.
Zur Publikation

Mohme S, Goebeler M, Hamm H (2021)
A child with blistering skin lesions: a crown of jewels.
Eur J Dermatol. 2021 Apr 1;31(2):285-286. 
Zur Publikation

Quaglino P, Prince HM, Cowan R, Vermeer M, Papadavid L, Bagot M, Servitjie O, Berti E, Guenova E, Stadler R, Querfeld C, Busschots AM, Hodak E, Patsatsi A, Sanches J, Maule M, Yoo J, Kevin M, Fava P, Ribero S, Zocchi L, Rubatto M, Fierro MT, Wehkamp U, Marshalko M, Mitteldorf C, Akilov O, Ortiz-Romero P, Estrach T, Vakeva L, Enz PA, Wobser M, Bayne M, Jonak C, Rubeta M, Forbes A, Bates A, Battistella M, Amel-Kashipaz R, Vydianath B, Combalia A, Georgiou E, Hauben E, Hong EK, Jost M, Knobler R, Amitay-Laish I, Miyashiro D, Cury-Martins J, Martinez X, Muniesa C, Prag-Naveh H, Nikolaou V, Quint K, Ram-Wolff C, Rieger K, Stranzenbach R, Szepesi Á, Alberti-Violetti S, Felicity E, Cerroni L, Kempf W, Whittaker S, Willemze R, Kim Y, Scarisbrick JJ (2021)
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).
Br J Dermatol. 2021 Apr;184(4):722-730.
Zur Publikation

Schmitt T, Egu DT, Walter E, Sigmund AM, Eichkorn R, Yazdi A, Schmidt E, Sárdy M, Eming R, Goebeler M, Waschke J (2021)
Ca2+ signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.
Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20091.
Zur Publikation

Wedi B, Aberer W, Brockow K, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, Merk HF, Mülleneisen N, Ott H, Pfützner W, Röseler S, Ruëff F, Sunderkötter C, Trautmann A, Treudler R, Worm M, Wurpts G (2021)
Induction of penicillin tolerance during pregnancy : Allergological opinion on the recommendation of the current Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002).
Hautarzt. 2021 Apr;72(4):349-353.
Zur Publikation

Lodde G, Forschner A, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Schilling B, Loquai C, Berking C, Hüning S, Schatton K, Gebhardt C, Eckardt J, Gutzmer R, Reinhardt L, Glutsch V, Nikfarjam U, Erdmann M, Stang A, Kowall B, Roesch A, Ugurel S, Zimmer L, Schadendorf D, Livingstone E (2021)
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.
Cancers 2021, 13, 2319. doi.org/10.3390/cancers13102319 
Zur Publikation

Hodak E, Sherman S, Papadavid E, Bagot M, Querfeld C, Quaglino P, Prince HM, Ortiz-Romero PL, Stadler R, Knobler R, Guenova E, Estrach T, Patsatsi A, Leshem YA, Prague-Naveh H, Berti E, Alberti-Violetti S, Cowan R, Jonak C, Nikolaou V, Mitteldorf C, Akilov O, Geskin L, Matin R, Beylot-Barry M, Vakeva L, Sanches JA, Servitje O, Weatherhead S, Wobser M, Yoo J, Bayne M, Bates A, Dunnill G, Marschalko M, Buschots AM, Wehkamp U, Evison F, Hong E, Amitay-Laish I, Stranzenbach R, Vermeer M, Willemze R, Kempf W, Cerroni L, Whittaker S, Kim YH, Scarisbrick JJ (2021)
Cutaneous Lymphoma International Consortium (CLIC) institutions. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
Br J Dermatol. 2021 Mar;184(3):524-531.
Zur Publikation

Hoesl C, Fröhlich T, Posch C, Kneitz H, Goebeler M, Schneider MR, Dahlhoff M (2021)
The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Mol Oncol. 2021 Mar 31. 
Zur Publikation

Kempf W, Mitteldorf C, Battistella M, Willemze R, Cerroni L, Santucci M, Geissinger E, Jansen P, Vermeer MH, Marschalko M, Papadavid E, Piris MA, Ortiz-Romero PL, Novelli M, Paulli M, Quaglino P, Ranki A, Rodríguez Peralto JL, Wobser M, Auschra B, Robson A (2021)
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):658-668.
Zur Publikation

Marquardt A, Solimando AG, Kerscher A, Bittrich M, Kalogirou C, Kübler H, Rosenwald A, Bargou R, Kollmannsberger P, Schilling B, Meierjohann S, Krebs M (2021)
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.
Front Oncol. 2021 Mar 15;11:621278.
Zur Publikation

Kerstan A, Dieter K, Niebergall-Roth E, Dachtler AK, Kraft K, Stücker M, Daeschlein G, Jünger M, Görge T, Meyer-Pannwitt U, Erfurt-Berge C, von Engelhardt C, Klare A, Pfeiffer C, Esterlechner J, Schröder HM, Gasser M, Waaga-Gasser AM, Goebeler M, Ballikaya S, Sadeghi S, Murphy GF, Orgill DP, Frank NY, Ganss C, Scharffetter-Kochanek K, Frank MH, Kluth MA (2021)
Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: a Phase I/IIa Clinical Trial.
JID Innovations (2021, im Druck)
Zur Publikation

Fan K, Spassova I, Gravemeyer J, Ritter C, Horny K, Lange A, Gambichler T, Ødum N, Schrama D, Schadendorf D, Ugurel S, Becker JC (2021)
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Oncogene. 2021 Feb;40(5):980-996.
Zur Publikation

Frings VG, Roth S, Rosenwald A, Goebeler M, Geissinger E, Wobser M (2021)
EBER in situ-hybridization in subcutaneous aluminum granulomas/lymphoid hyperplasia: a diagnostic clue to differentiate injection-associated lymphoid hyperplasia from other forms of pseudolymphomas and cutaneous lymphomas.
J Cutan Pathol. 48:625-631
Zur Publikation

Haggenmüller S, Goebeler M, Schilling B, Brinker T (2021)
Skin Cancer Classification via Convolutional Neural Networks: Systematic Review of Studies Involving Human Experts.
Eur J Cancer (2021, im Druck)
Zur Publikation

Jägle S, Juratli HA, Hickman G, Süssmuth K, Boente MC, Kopp J, Kirchmeier P, Zimmer A, Happle R, Bourrat E, Hamm H, Fischer J (2021)
Porokeratosis Plantaris, Palmaris et Disseminata Caused by Con- genital Pathogenic Variants in the MVD Gene and Loss of Hetero-zygosity in Affected Skin.
Acta Derm Venereol. 2021 Feb 16;101(2):
Zur Publikation 

Kerstan A, Niebergall-Roth E, Esterlechner J, Schröder HM, Gasser M, Waaga-Gasser AM, Goebeler M, Rak K, Schrüfer P, Endres S, Hagenbusch P, Kraft K, Dieter K, Ballikaya S, Stemler N, Sadeghi S, Tappenbeck N, Murphy GF, Orgill DP, Frank NY, Ganss C, Scharffetter-Kochanek K, Frank MH, Kluth MA (2021)
Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data.
Cytotherapy. 2021 Feb;23(2):165-175.
Zur Publikation

Sturm GJ, Herzog SA, Aberer W, Alfaya Arias T, Antolín-Amérigo D, Bonadonna P, Boni E, Bożek A, Chełmińska M, Ernst B, Frelih N, Gawlik R, Gelincik A, Hawranek T, Hoetzenecker W, Jiménez Blanco A, Kita K, Kendirlinan R, Košnik M, Laipold K, Lang R, Marchi F, Mauro M, Nittner-Marszalska M, Poziomkowska-Gęsicka I, Pravettoni V, Preziosi D, Quercia O, Reider N, Rosiek-Biegus M, Ruiz-Leon B, Schrautzer C, Serrano P, Sin A, Sin BA, Stoevesandt J, Trautmann A, Vachová M, Arzt-Gradwohl L (2021)
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.
Allergy. 2021 Feb 19. doi: 10.1111/all.14785.
Zur Publikation

Kneitz H, Goebeler M, Rütten A (2021)
Nevus sebaceus of the scalp with stepwise progression into invasive syringocystadenocarcinoma papilliferum.
Am J Dermatopathol (2021, im Druck)
Zur Publikation

Maron RC, Haggenmüller S, von Kalle C, Utikal JS, Meier F, Gellrich FF, Hauschild A, French LE, Schlaak M, Ghoreschi K, Kutzner H, Heppt MV, Haferkamp S, Sondermann W, Schadendorf D, Schilling B, Hekler A, Krieghoff-Henning E, Kather JN, Fröhling S, Lipka DB, Brinker TJ (2021)
Robustness of convolutional neural networks in recognition of pigmented skin lesions.
Eur J Cancer. 2021 145:81-91.
Zur Publikation

Salviano-Silva A, Farias TDJ, Bumiller-Bini V, Castro MS, Lobo-Alves SC, Busch H, Pföhler C, Worm M, Goebeler M, van Beek N, Franke A, Wittig M, Zillikens D, de Almeida RC, Hundt JE, Boldt ABW, Ibrahim S, Augusto DG, Petzl-Erler ML, Schmidt E, Malheiros D (2021)
Genetic variability of immune-related lncRNAs: polymorphisms in LINC-PINT and LY86-AS1 are associated with pemphigus foliaceus susceptibility.
Exp Dermatol. 2021 Jan 4. doi: 10.1111/exd.14275
Zur Publikation

Schargus M, Langhorst CA, Joachim S, Frings A, Krause K, Reifenberger J, Geerling G, Frings VG (2021)
Hidradenitis Suppurativa is Associated with Symptoms of Keratoconjunctivitis Sicca.
Curr Eye Res. 2021 Jan;46(1):23-30. 
Zur Publikation

Steeb T, Wessely A, Alter M, Bayerl C, Bender A, Bruning G, Dabrowski E, Debus D, Devereux N, Dippel E, Drexler K, Dücker P, Dummer R, Emmert S, Elsner P, Enk A, Gebhardt C, Gesierich A, Goebeler M, Goerdt S, Goetze S, Gutzmer R, Haferkamp S, Hansel G, Hassel JC, Heinzerling L, Kähler KC, Kaume KM, Krapf W, Kreuzberg N, Lehmann P, Livingstone E, Löffler H, Loquai C, Mauch C, Mangana J, Meier F, Meissner M, Moritz RKC, Maul LV, Müller V, Mohr P, Navarini A, Van Nguyen A, Pfeiffer C, Pföhler C, Posch C, Richtig E, Rompel R, Sachse MM, Sauder S, Schadendorf D, Schatton K, Schulze HJ, Schultz E, Schilling B, Schmuth M, Simon JC, Streit M, Terheyden P, Thiem A, Tüting T, Welzel J, Weyandt G, Wesselmann U, Wollina U, Ziemer M, Zimmer L, Zutt M, Berking C, Schlaak M, Heppt MV; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma) (2021)
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
J Cancer Res Clin Oncol. 2021 147:1763-1771.
Zur Publikation

Sunderkötter C, Wohlrab J, Hamm H (2021)
Epidemiologie, Diagnostik und Therapie der Skabies.
Dt. Ärzteblatt (2021, im Druck)
Zur Publikation

Thiem A, Has C, Diem A, Klausegger A, Hamm H, Emmert S (2021)
Wundtherapie mit kaltem Plasma bei Epidermolysis bullosa dystrophica.
Hautarzt (2021, im Druck)
Zur Publikation

Wedi B, Aberer W, Brockow K, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, Merk HF, Mülleneisen N, Ott H, Pfützner W, Röseler S, Ruëff F, Sunderkötter C, Trautmann A, Treudler R, Worm M, Wurpts G (2021)
Induction of penicillin tolerance during pregnancy: Allergological opinion on the recommendation of the current AWMF Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002).
Allergol Select. 2021 Jan 26;5:67-71. doi: 10.5414/ALX02224E. eCollection
Zur Publikation

Wessely A, Steeb T, Berking C, Schlaak M, Heppt MV; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma) (2021)
Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group.
Eur J Cancer. 2021 Jan;143:43-45. 
Zur Publikation

Publikationen 2020

Adam C, Fusi L, Weiss N, Goller SG, Meder K, Frings VG, Kneitz H, Goebeler M, Houben R, Schrama D, Schmidt M (2020)
Efficient suppression of NRAS-driven melanoma by co-inhibition of ERK1/2 and ERK5 MAPK pathways.
J Invest Dermatol. 2020 Dec;140(12):2455-2465

Amaral T, Kiecker F, Schaefer S, Stege H, Kaehler K, Terheyden P, Gesierich A, Gutzmer R, Haferkamp S, Uttikal J, Berking C, Rafei-Shamsabadi D, Reinhardt L, Meier F, Karoglan A, Posch C, Gambichler T, Pfoehler C, Thoms K, Tietze J, Debus D, Herbst R, Emmert S, Loquai C, Hassel JC, Meiss F, Tueting T, Heinrich V, Eigentler T, Garbe C, Zimmer L (2020). Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG study in 380 patients. J Immunother Cancer. 2020 Mar,8(1):e000333.

Azeem M, Kader H, Kerstan A, Hetta HF, Serfling E, Goebeler M, Muhammad K (2020)
Intricate Relationship Between Adaptive and Innate Immune System in Allergic Contact Dermatitis.
Yale J Biol Med. 2020 Dec 29;93(5):699-709

Bröcker EB, Buhl T, Frank J, Fritsch P, Goerdt S, Gollnick HPM, Schön MP (2020)
Wolfram Sterry und das Journal der Deutschen Dermatologischen Gesellschaft - Erinnerung an eine Erfolgsgeschichte in mehreren Akten.
J Dtsch Dermatol Ges. 2020 Dec;18(12):1531-1532

Bröcker EB (2020)
Ein JDDG-Heft für Peter Fritsch zum 80. Geburtstag.
J Dtsch Dermatol Ges. 2020 Nov;18(11):1210.

Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M (2020)
COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen.
J Dtsch Dermatol Ges. 2020 Aug;18(8):815-825.

Conway JR, Dietlein F, Taylor-Weiner A, AlDubayan S, Vokes N, Keenan T, Reardon B, He MX, Margolis CA, Weirather JL, Haq R, Schilling B, Stephen Hodi F, Schadendorf D, Liu D, Van Allen EM (2020)
Integrated molecular drivers coordinate biological and clinical states in melanoma.
Nat Genet. 2020 Dec;52(12):1373-1383.

Erhard F, Dölken L, Schilling B, Schlosser A (2020)
Identification of the Cryptic HLA-I Immunopeptidome.
Cancer Immunol Res. 2020 Aug;8(8):1018-1026.

Fan K, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, Shuda M, Schrama D, Becker JC (2020)
MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.
J Invest Dermatol. 2020 Jan;140(1):56-65.e3. 

Fan K, Zebisch A, Horny K, Schrama D, Becker JC (2020)
Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma.
Cancers (Basel). 12(3):529.

Fan K, Zebisch A, Horny K, Schrama D, Becker JC (2020)
Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma.
Cancers (Basel). 2020 Feb 25;12(3):529.

Frings VG, Goebeler M, Kneitz H (2020)
Dermpath & Clinic: Where the shoe pinches - painful plantar plaque.
Eur J Dermatol. 2020 Aug 1;30(4):447-449.

Frings VG, Goebeler M, Kneitz H (2020)
Dermpath & Clinic: Too many irons in the fire.
Eur J Dermatol. 2020 Oct 1;30(5):624-625

Garbe C, Keim U, Suciu S, Amaral T, Eigentler TK, Gesierich A, Hauschild A, Heinzerling L, Kiecker F, Schadendorf D, Stadler R, Sunderkötter C, Tüting T, Utikal J, Wollina U, Zouboulis CC, Keilholz U, Testori A, Martus P, Leiter U, Eggermont AMM; German Central Malignant Melanoma Registry and the European Organisation for Research and Treatment of Cancer (2020)
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts.
J Clin Oncol. 2020 Aug 1;38(22):2543-2551.

Glutsch V, Amaral T, Garbe C, Thoms KM, Mohr P, Hauschild A, Schilling B (2020)
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase.
Acta Derm Venereol. 2020 Jun 11;100(13):adv00174

Grän F, Kerstan A, Serfling E, Goebeler M, Muhammad K (2020)
Current Developments in the Immunology of Psoriasis.
Yale J Biol Med. 93(1):97-110.

Grän F, Emmerich K, Mohme S, Goebeler M, Gesierich A (2020)
Vitiligo-like lesions developing upon immune checkpoint inhibition in advanced melanoma.
Eur J Dermatol. 30(1):72-73.

Haeger A, Alexander S, Vullings M, Kaiser FMP, Veelken C, Flucke U, Koehl GE, Hirschberg M, Flentje M, Hoffman RM, Geissler EK, Kissler S, Friedl P (2020)
Collective cancer invasion forms an integrin-dependent radioresistant niche.
J Exp Med. 2020 Jan 6,217(1). 217(1):e20181184.

Haferkamp S, Alter M, Debus D, Schilling B, Pinter A, Terheyden P, Utikal JS, Sachse MM, Haalck T, Wolf IH (2020)
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.
Adv Ther. 2020 Aug;37(8):3619-3629

Hekler A, Kather JN, Krieghoff-Henning E, Utikal JS, Meier F, Gellrich FF, Upmeier Zu Belzen J, French L, Schlager JG, Ghoreschi K, Wilhelm T, Kutzner H, Berking C, Heppt MV, Haferkamp S, Sondermann W, Schadendorf D, Schilling B, Izar B, Maron R, Schmitt M, Fröhling S, Lipka DB, Brinker TJ (2020)
Effects of Label Noise on Deep Learning-Based Skin Cancer Classification.
Front Med (Lausanne). 2020 May 6,7:177.

Heck J, Olk J, Kneitz H, Hamm H, Goebeler M (2020)
Long-standing morphea and the risk of squamous cell carcinoma of the skin.
J Dtsch Dermatol Ges. 2020 Jul,18(7):669-673.

Hosp C, Benoit S, Goebeler M, Stoevesandt J (2020)
Rituximab-mediated late onset neutropenia in autoimmune blistering diseases: negligible or under-estimated threat?
J Dtsch Dermatol Ges
. 2020 Oct,18(10):1162-1164.

Houben R, Ebert M, Hesbacher S, Kervarrec T, Schrama D (2020)
Merkel Cell Polyomavirus Large T Antigen is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells.
Viruses. 2020 Oct 14;12(10):1162.

Jessen C, Kreß JKC, Baluapuri A, Hufnagel A, Schmitz W, Kneitz S, Roth S, Marquardt A, Appenzeller S, Ade CP, Glutsch V, Wobser M, Friedmann-Angeli JP, Mosteo L, Goding CR, Schilling B, Geissinger E, Wolf E, Meierjohann S (2020)
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.
Oncogene. 2020 Oct;39(44):6841-6855.

Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, Bergman R, Bernard P, Borradori L, Caproni M, Caux F, Cianchini G, Daneshpazhooh M, De D, Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R, Guenther C, Hofmann S, Ioannides D, Kowalewski C, Ludwig R, Lim YL, Marinovic B, Marzano AV, Mascaró JM Jr, Mimouni D, Murrell DF, Pincelli C, Squarcioni CP, Sárdy M, Setterfield J, Sprecher E, Vassileva S, Wozniak K, Yayli S, Zambruno G, Zillikens D, Hertl M, Schmidt E (2020)
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1900-1913

Kervarrec T, Zaragoza J, Gaboriaud P, Berthon P, Fromont G, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Michenet P, Maillard H, Houben R, Schrama D, Caille A, Touzé A, Guyétant S, Samimi M (2020, online ahead of print)
Merkel cell carcinoma of lymph nodes without a skin primary tumor: a potential metastatic neoplasia associated with a brisk immune response.
J Am Acad Dermatol. S0190-9622(20)30535-1. doi: 10.1016/j.jaad.2020.03.108.

Kervarrec T, Aljundi M, Appenzeller S, Samimi M, Maubec E, Cribier B, Deschamps L, Sarma B, Sarosi EM, Berthon P, Levy A, Bousquet G, Tallet A, Touzé A, Guyétant S, Schrama D, Houben R (2020)
Polyomavirus-Positive Merkel Cell Carcinoma Derived from a Trichoblastoma Suggests an Epithelial Origin of this Merkel Cell Carcinoma.
J Invest Dermatol. 140(5):976-985.

Kervarrec T, Tallegas M, Schrama D, Houben R, Ollier J, Clémenceau B, Vié H, Touzé A, Samimi M, Guyétant S (2020)
BerEP4 positivity in Merkel cell carcinoma: a potential diagnosis pitfall.
J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.16482.

Knispel S, Stang A, Zimmer L, Lax H, Gutzmer R, Heinzerling L, Weishaupt C, Pföhler C, Gesierich A, Herbst R, Kaehler KC, Weide B, Berking C, Loquai C, Utikal J, Terheyden P, Kaatz M, Schlaak M, Kreuter A, Ulrich J, Mohr P, Dippel E, Livingstone E, Becker JC, Weichenthal M, Chorti E, Gronewold J, Schadendorf D, Ugurel S (2020)
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
J Immunother Cancer. (1):e000395.

Kosnopfel C, Sinnberg T, Sauer B, Niessner H, Muenchow A, Fehrenbacher B, Schaller M, Mertens PR, Garbe C, Thakur BK, Schittek B (2020)
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion.
Cancers (Basel). 2020 Aug 18;12(8):2328. doi: 10.3390/cancers12082328

Krebs M, Solimando AG, Kalogirou C, Marquardt A, Frank T, Sokolakis I, Hatzichristodoulou G, Kneitz S, Bargou R, Kübler H, Schilling B, Spahn M, Kneitz B (2020)
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro.
J Clin Med. 2020 Mar 2;9(3):670.

Kroiß M, Schilling B, Deutschbein T (2020)
Endocrine side effects of cancer immunotherapy.
Dtsch Med Wochenschr. 2020 Dec;145(24):1736-1741.

Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, Hassel JC, Glutsch V, Sirokay J, Schlecht N, Rübben A, Gambichler T, Schatton K, Pfoehler C, Franklin C, Terheyden P, Haferkamp S, Mohr P, Bischof L, Livingstone E, Zimmer L, Weichenthal M, Schadendorf D, Meiwes A, Keim U, Garbe C, Becker JC, Ugurel S (2020)
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.
J Immunother Cancer. 2020 Oct;8(2):e000897. doi: 10.1136/jitc-2020-000897.

Livingstone E, Zaremba A, Horn S, Ugurel S, Casalini B, Schlaak M, Hassel JC, Herbst R, Utikal JS, Weide B, Gutzmer R, Meier F, Koelsche C, Hadaschik E, Sucker A, Reis H, Merkelbach-Bruse S, Siewert M, Sahm F, von Deimling A, Cosgarea I, Zimmer L, Schadendorf D, Schilling B, Griewank KG (2020)
GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
Br J Dermatol. 2020 Nov;183(5):928-939.

Maurus K, Appenzeller S, Roth S, Brändlein S, Kneitz H, Goebeler M, Rosenwald A, Geissinger E, Wobser M (2020)
Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.
J Invest Dermatol. 2020 Oct;140(10):2023-2031.

Maron RC, Utikal JS, Hekler A, Hauschild A, Sattler E, Sondermann W, Haferkamp S, Schilling B, Heppt MV, Jansen P, Reinholz M, Franklin C, Schmitt L, Hartmann D, Krieghoff-Henning E, Schmitt M, Weichenthal M, von Kalle C, Fröhling S, Brinker TJ (2020)
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study.
J Med Internet Res. 2020 Sep 11;22(9):e18091.

Mayser P, Nenoff P, Reinel D, Abeck D, Brasch J, Daeschlein G, Effendy I, Ginter-Hanselmayer G, Gräser Y, Hipler UC, Höger P, Kolb-Mäurer A, Ott H, Schaller M, Zidane M (2020)
S1-Leitlinie Tinea capitis.
J Dtsch Dermatol Ges. 2020 Feb;18(2):161-180.

Michielin O, van Akkooi A, Lorigan P, Ascierto PA, Dummer R, Robert C, Arance A, Blank CU, Chiarion Sileni V, Donia M, Faries MB, Gaudy-Marqueste C, Gogas H, Grob JJ, Guckenberger M, Haanen J, Hayes AJ, Hoeller C, Lebbé C, Lugowska I, Mandalà M, Márquez-Rodas I, Nathan P, Neyns B, Olofsson Bagge R, Puig S, Rutkowski P, Schilling B, Sondak VK, Tawbi H, Testori A, Keilholz U (2020)
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.
Ann Oncol. 2020 Nov;31(11):1449-1461.

Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J (2020)
Impfen bei Immunsuppression: ein Leitfaden für die dermatologische Praxis.
J Dtsch Dermatol Ges. 2020 Jul;18(7):699-725.

Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, Hauben E, Knobler R, Porkert S, Fassnacht C, Cowan R, Papadavid E, Beylot-Barry M, Berti E, Alberti Violetti S, Estrach T, Matin R, Akilov O, Vakeva L, Prince M, Bates A, Bayne M, Wachsmuch R, Wehkamp U, Marschalko M, Servitje O, Turner D, Weatherhead S, Wobser M, Sanches JA, McKay P, Klemke D, Peng C, Howles A, Yoo J, Evison F, Scarisbrick J (2020)
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2020 Mar;182(3):770-779.

Orouji E, Peitsch WK, Orouji A, Houben R, Utikal J (2020)
Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma.
Cancers (Basel). 2020 Apr 24;12(4):E1057.

Orouji E, Peitsch WK, Orouji A, Houben R, Utikal J (2020)
Oncogenic Role of an Epigenetic Reader of m6A RNA Modification: YTHDF1 in Merkel Cell Carcinoma.
Cancers (Basel). 2020 Jan 14;12(1):202.

Reichel A, Grothaus J, Ott H (2020)
Pityriasis lichenoides acuta (PLEVA) pemphigoides: A rare bullous variant of PLEVA.
Pediatr Dermatol. 2020 Jul;37(4):710-712.

Reichel A, Röding K, Stoevesandt J, Trautmann A(2020)
De-labelling antibiotic allergy through five key questions.
Clin Exp Allergy. 2020 Apr;50(4):532-535.

Rongisch R, Schmidt E, Deresz N, Deresz K, Schöfer H, Schäkel K, Jakob T, Maurer M, Sticherling M, Sunderkötter C, Babilas P, Spornraft-Ragaller P, Traidl-Hoffmann C, Gläser R, Hartmann K, Kolb-Mäurer A, Wenzel J, Biedermann T, Homey B, Pfützner W, Weid F, Fischer M, Linder R, von Stebut E (2020)
Travel-associated infectious skin diseases.
J Dtsch Dermatol Ges. 2020 Jul;18(7):730-733.

Sarma B, Willmes C, Angerer L, Adam C, Becker JC, Kervarrec T, Schrama D, Houben R (2020)
Artesunate Affects T Antigen Expression and Survival of Virus-Positive Merkel Cell Carcinoma.
Cancers (Basel). 2020; Apr 9;12(4):E919.

Schargus M, Brückner KA, Frings VG, Frings A (2020)
Bilateral conjunctival chemosis.
Ophthalmologe. 2020 Feb;117(2):154-157.doi: 10.1007/s00347-019-00960-2. 

Schlegel S, Hamm H, Reichel A, Kneitz H, Ernestus K, Andres O, Wiegering VG, Eyrich M, Wölfl M, Schlegel PG (2020)
Neonatal Acute Lymphoblastic Leukemia with t(9;11) Translocation Presenting as Blueberry Muffin Baby: Successful Treatment by ALL-BFM Induction Therapy, Allogeneic Stem Cell Transplantation from an Unrelated Donor, and PCR-MRD-Guided Post-Transplant Follow-Up.
Am J Case Rep. 2020 Oct 27;21:e927153

Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Nast A, Orzechowski HD, Pfeiffer C, Schuster V, Sitaru C, Zidane M, Zillikens D, Worm M (2020)
S2k guidelines for the treatment of pemphigus vulgaris/ foliaceus and bullous pemphigoid: 2019 update.
J Deutsch Dermatol Ges 2020 May; 18:516-526.

Schnuch A, Schubert S, Lessmann H, Geier J; IVDK (2020)
The methylisothiazolinone epidemic goes along with changing patients' characteristics - After cosmetics, industrial applications are the focus.
Contact Dermatitis. 2020 Feb;82(2):87-93.

Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K (2020) 
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen.
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-809

Schrüfer P, Brockow K, Stoevesandt J, Trautmann A (2020)
Predominant patterns of β-lactam hypersensitivity in a single German Allergy Center: exanthem induced by aminopenicillins, anaphylaxis by cephalosporins.
Allergy Asthma Clin Immunol. 2020 Nov 17;16(1):102.

Schummer P, Schilling B, Gesierich A (2020)
Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?
Am J Clin Dermatol. 2020 Aug;21(4):493-504.

Spassova I, Ugurel S, Terheyden P, Sucker A, Hassel JC, Ritter C, Kubat L, Habermann D, Farahpour F, Saeedghalati M, Peiffer L, Kumar R, Schrama D, Hoffmann D, Schadendorf D, Becker JC (2020)
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma.
Clin Cancer Res. 2020 May 1;26(9):2257-2267.

Stoevesandt J, Sturm GJ, Bonadonna P, Oude Elberink JNG, Trautmann A (2020)
Risk factors and indicators of severe systemic insect sting reactions.
Allergy. 2020 Mar; 75(3): 535-545.doi: 10.1111/all.13945. 

Stoevesandt J, Heitmann J, Goebeler M, Benoit S (2020)
Neutropenia resulting from high-dose intravenous immunoglobulin in dermatological patients.
J Dtsch Dermatol Ges. 2020 Dec;18(12):1394-1403.

Trautmann A, Brockow K, Stoevesandt J (2020)
Metamizole-induced reactions as a paradigm of drug hypersensitivity: Non-allergic reactions, anaphylaxis, and delayed-type allergy.
Clin Exp Allergy. 2020 Sep;50(9):1103-1106.

Ueberschaar S, Goebeler M, Kneitz H (2020)
CD10-Positive Cutaneous PEComa: An Extremely Rare Skin Tumour.
Case Rep Dermatol. 2020 Nov 2;12(3):192-198

Ugurel S, Schadendorf D, Horny K, Sucker A, Schramm S, Utikal J, Pföhler C, Herbst R, Schilling B, Blank C, Becker JC, Paschen A, Zimmer L, Livingstone E, Horn PA, Rebmann V (2020)
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma.
Ann Oncol. 2020 Jan;31(1):144-152.

Vilas Boas P, Frings V, Gran F, Lesort C, Machado Á, Arianayagam S (2020)
What's new this month?
Eur J Dermatol. 2020 Apr 1;30(2):210-211.

Wallstabe J, Bussemer L, Groeber-Becker F, Freund L, Alb M, Dragan M, Waaga-Gasser AM, Jakubietz R, Kneitz H, Rosenwald A, Rebhan S, Walles H, Mielke S (2020) Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeutics.
ALTEX. 2020;37(3):429-440.

Weber J, Glutsch V, Geissinger E, Haug L, Lock JF, Schneider F, Kneitz H, Goebeler M, Schilling B, Gesierich A (2020)
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease.
Br J Dermatol. 2020 Sep;183(3):559-563.

Westphalen BC, Bokemeyer C, Büttner R, Fröhling S, Gaidzik VI, Glimm H, Hacker UT, Heinemann V, Illert AL, Keilholz U, Kindler T, Kirschner M, Schilling B, Siveke JT, Schroeder T, Tischler V, Wagner S, Weichert W, Zips D, Loges S (2020)
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’.
Eur J Cancer (2020) 135:1-7.

Wobser M, Goebeler M (2020)
Cutaneous lymphomas : Clinical presentation - diagnosis - treatment.
Pathologe. 2020 Feb;41(1):79-94.

Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F (2020)
Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie.
Allergo J. 2020;29(8):16-21

Worm M, Ballmer-Weber B, Brehler R, Cuevas M, Gschwend A, Hartmann K, Hawranek T, Hötzenecker W, Homey B, Jakob T, Novak N, Pickert J, Saloga J, Schäkel K, Trautmann A, Treudler R, Wedi B, Sturm G, Rueff F (2020)
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic.
Allergo J Int. 2020;29(8):257-261.

Wurpts G, Aberer W, Dickel H, Brehler R, Jakob T, Kreft B, Mahler V, Merk HF, Mülleneisen N, Ott H, Pfützner W, Röseler S, Ruëff F, Sitter H, Sunderkötter C, Trautmann A, Treudler R, Wedi B, Worm M, Brockow K (2020)
Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (ÖGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG).
Allergol Select. 2020 May 28;4:11-43.

Zimmer L, Livingstone E, Hassel JC, Fluck M, Eigentler T, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kieker F, Dippel E, Rösch A, Simon JC, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D on behalf of the Dermatologic Cooperative Oncology Group (2020)
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet. 2020; 395(10236):1558-1568.

Publikationen 2019

Almanzar G, Schmalzing M, Klein M, Hilligardt D, Morris P, Höfner K, Hajj NE, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M (2019)
Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosis.
Eur J Dermatol. 29(5):468-476.

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald R, Schartl M, Goebeler M, Meierjohann S.(2019)
Identification of  patient-specific mutations reveals dual pathway activation in most melanoma patients and activated receptor tyrosine kinases in BRAF/NRAS wildtype melanomas.
Cancer 2019;125, 586-600.

Ballin N, Hotz A, Bourrat E, Küsel J, Oji V, Bouadjar B, Brognoli D, Hickman G, Heinz L, Vabres P, Marrakchi S, Leclerc-Mercier S, Irvine A, Tadini G, Hamm H, Has C, Blume-Peytavi U, Mitter D, Reitenbach M, Hausser I, Zimmer AD, Alter S, Fischer J (2019)
 Genetical, clinical, and functional analysis of a large international cohort of patients with autosomal recessive congenital ichthyosis due to mutations in NIPAL4.
Hum Mutat. 40(12):2318-2333.

Boas PV, Arianayagam S, Machado ÁCDS, Gran F, Lesort C, Frings V (2019)
What's new this month?
Eur J Dermatol. 29(2):238-239.

Brinker TJ, Hekler A, Enk AH, Berking C, Haferkamp S, Hauschild A, Weichenthal M, Klode J, Schadendorf D, Holland-Letz T, von Kalle C, Fröhling S, Schilling B, Utikal JS (2019)
Deep neural networks are superior to dermatologists in melanoma image classification.
Eur J Cancer. 119:11-17.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C (2019)
Collaborators. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.
Eur J Cancer. 113:47-54.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Fröhling S, Utikal JS, von Kalle C (2019)
Collaborators. A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.
Eur J Cancer. 111:148-154.

Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, Karoglan A, von Kalle C, Weichenthal M, Sattler E, Schadendorf D, Gaiser MR, Klode J, Utikal JS (2019)
Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark.
Eur J Cancer. 111:30-37.

Da Silva Machado ÁC, Vilas Boas P, Arianayagam S, Gran F, Lesort C, Frings V (2019)
What's new this month?
Eur J Dermatol. 29(3):345-346.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M (2019)
S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2.
J Dtsch Dermatol Ges. 17(9):959-974.

Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M (2019)
S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1.
J Dtsch Dermatol Ges. 17(8):856-870.

Emmerich K, Kolb-Mäurer A, Goebeler M. Kutane (2019)
Nichttuberkulöse Mykobakteriosen.
Akt Dermatol. 2019;45, 47-5.

Felcht M, Klemke CD, Nicolay JP, Weiss C, Assaf C, Wobser M, Schlaak M, Hillen U, Moritz R, Tantcheva-Poor I, Nashan D, Beyer M, Dippel E, Müller CSL, Sachse MM, Meiss F, Géraud C, Marx A, Goerdt S, Geissinger E, Kempf W (2019)
Primär kutanes diffus-großzelliges B-Zell-Lymphom, NOS oder leg type: klinische, morphologische und prognostische Unterschiede.
J Dtsch Dermatol Ges. 17(3):275-286.

Franklin C, Bruderek K, Schilling B, Brandau S (2019)
Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs.
J Leukoc Biol. 106(2):481-493.

Frings VG, Müller D, Storz G, Rossi A, Sennefelder H, Adam C, Goebeler M, Groeber-Becker FK, Schmidt M (2019)
Improved metal allergen reactivity of artificial skin models by integration of Toll-like receptor 4-positive cells.
Contact Dermatitis. 81(4):254-261.

Frings VG, Goebeler M, Kneitz H. Dermpath (2019)
Clinic: Multiple nodules in the axillae: is it that old chestnut Hidradenitis suppurativa again?
Eur J Dermatol. 29(5):569-570.

Frings VG, Goebeler M, Kneitz H (2019)
DermPath: Disseminated papules on the upper body: a diagnostic challenge.
Eur J Dermatol. 29(3):346-347.

Frings VG, Bauer B, Glöditzsch M, Goebeler M, Presser D (2019)
Assessing the psychological burden of patients with hidradenitis suppurativa.
Eur J Dermatol. 2019;29(3):294-301.

Frings VG, Sennefelder H, Presser D, Goebeler M, Schmidt M (2019)
Altered NOX expression does not seem to account for epidermal NLRP3 inflammasome activation in Hidradenitis Suppurativa.
Br J Dermatol. 181(2):391-392.

Gaffal E, Eming R, Fabri M, Gebhardt C, Stary G, Eyerich S, Hölzel M, Kosnopfel C, Neubert E, Rauer D, Rodríguez E, Thiem A, von Meyenn L, Buhl T (2019)
46th annual congress of the "Arbeitsgemeinschaft Dermatologische Forschung" in Munich, Germany.
Exp Dermatol. 28(9):1094-1099
.

Gassenmaier M, Keim U, Leiter U, Eigentler TK, Röcken M, Gesierich A, Moritz RKC, Heinzerling L, Tüting T, Wollina U, Garbe C (2019)
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry.
J Am Acad Dermatol. 80(5):1299-1307.e7.

Giehl K, Hamm H, Has C (2019)
Role of the dermatologist in recognizing syndromes.
Hautarzt. 70(7):472-473.

Giner T, Benoit S, Goebeler M (2019)
Die Sarkoidose aus dermatologischer Perspektive.
Akt Dermatol. 2019;45, 40-46.

Glutsch V, Hamm H, Goebeler M (2019)
Zinkmangeldermatosen.
J Dtsch Dermatol Ges. 2019;17(6):589-596.

Glutsch V, Kneitz H, Goebeler M, Gesierich A, Schilling B (2019)
Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
Ann Oncol. 2019 Oct 1;30(10):1667-1668.

Glutsch V, Grän F, Weber J, Gesierich A, Goebeler M, Schilling B (2019)
Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy.
J Immunother Cancer. 7(1):181.

Goebeler M (2019)
Universitäre Dermatologie, Venerologie und Allergologie in Würzburg: Tradition und Innovation.
Akt Dermatol. 2019;45, 5-6.

Grän F, Arianayagam S, Lesort C, Machado Á, Vilas Boas P, Frings VG (2019)
What's new this month?
Eur J Dermatol. 29(4):446-447.

Grän F, Goebeler M, Gesierich A (2019)
Bullous pemphigoid developing upon immune checkpoint inhibition with nivolumab.
Eur J Dermatol. 29(4):448-449.

Grän F, Goebeler M, Gesierich A (2019). Erythema multiforme-like rash upon anti-melanoma therapy with BRAF and MEK inhibitors. Eur J Dermatol. 29(1):107-108.

Hamm H, Emmerich K, Olk J (2019)
Pigmented macules as possible early signs of genetic syndromes.
Hautarzt. 70(7):506-513.

Hamm H, Stoevesandt J, Sunderkötter C (2019)
Scabies in old age.
Z Gerontol Geriatr. 52(8):795-807.

Heitmann J, Houben R, Schrama D, Goebeler M, Gesierich A, Schilling B (2019)
Das Merkelzellkarzinom: Ätiopathogenese und Management.
Akt Dermatol 45, 60-66.

Hekler A, Utikal JS, Enk AH, Hauschild A, Weichenthal M, Maron RC, Berking C, Haferkamp S, Klode J, Schadendorf D, Schilling B, Holland-Letz T, Izar B, von Kalle C, Fröhling S, Brinker TJ (2019)
Collaborators. Superior skin cancer classification by the combination of human and artificial intelligence.
Eur J Cancer. 120:114-121.

Heppt MV, Amaral T, Kähler KC, Heinzerling L, Hassel JC, Meissner M, Kreuzberg N, Loquai C, Reinhardt L, Utikal J, Dabrowski E, Gesierich A, Pföhler C, Terheyden P, Thoms KM, Zimmer L, Eigentler TK, Kirchberger MC, Stege HM, Meier F, Schlaak M, Berking C (2019)
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study.
J Immunother Cancer. 7(1):299.

Herz C, Wobser M, Fischer J, Hamm H. (2019)
Pachyonychia congenita und Steatocystoma multiplex durch Mutation im Keratin-17- Gen.
Akt Dermatol. 2019;45, 67-71.

Hoesl C, Fröhlich T, Hundt JE, Kneitz H, Goebeler M, Wolf R, Schneider MR, Dahlhoff M (2019)
The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
Mol Oncol. 13(11):2476-2492.

Ickrath F, Hosp C, Stolze I, Goebeler M, Trautmann A, Kerstan A (2019)
Successful treatment of progressive mucinous histiocytosis with multilayer CO2 laser ablation.
J Eur Acad Derm Venereol. 2019 Jul;33(7):e261-e262

Kahlert K, Hamm H, Goebeler M, Kerstan A (2019)
Pityriasis rubra pilaris – eine seltene entzündliche Dermatose mit vielen Facetten.
Akt Dermatol. 45, 32-39.

Kahlert K, Grän F, Muhammad K, Benoit S, Serfling E, Goebeler M, Kerstan A (2019)
Aberrant B cell subsets and immunoglobulin levels in patients with moderate-to-severe psoriasis.
Acta Derm Venereol. 2019;99(2):226-227.

Kervarrec T, Gaboriaud P, Tallet A, Leblond V, Arnorld F, Berthon P, Schweinitzer S, Larcher T, Guyétant S, Schrama D, Houben R, Samimi M, Touzé A (2019)
VEGF-A inhibition as a potential therapeutic approach in Merkel cell carcinoma.
J Invest Dermatol. 2019;139(3):736-739.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Touzé A, Samimi M, Guyétant S (2019)
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.
Mod Pathol. 2019;32(4):499-510.

Kervarrec T, Samimi M, Guyétant S, Sarma B, Chéret J, Blanchard E, Berthon P, Schrama D, Houben R, Touzé A (2019)
Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review.
Front Oncol. 2019;9:451.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Herfs M, Touzé A, Samimi M, Guyétant S (2019)
Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma.
Mod Pathol. 2019;32(11):1605-1616.

Kolb-Mäurer A, Sunderkötter C, Kukowski B, Meuth SG members of an expert meeting (2019)
An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.
BMC Neurol. 2019;19(1):130.

Krebs M, Behrmann C, Kalogirou C, Sokolakis I, Kneitz S, Kruithof-de Julio M, Zoni E, Rech A, Schilling B, Kübler H, Spahn M, Kneitz B (2019)
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.
Biomed Res Int. 2019 Nov;2019:6392748.

Kreft S, Gesierich A, Eigentler T, Franklin C, Valpione S, Ugurel S, Utikal J, Haferkamp S, Blank C, Larkin J, Garbe C, Schadendorf D, Lorigan P, Schilling B (2019)
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Eur J Cancer. 2019;116:207-215.

Lesort C, Grän F, Arianayagam S, Machado Á, Vilas Boas P, Frings VG (2019)
What's new this month?
Eur J Dermatol. 2019;29(5):568-569.

Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-Amon L, Zimmer L, Gutzmer R, Satzger I, Loquai C, Grabbe S, Vokes N, Margolis CA, Conway J, He MX, Elmarakeby H, Dietlein F, Miao D, Tracy A, Gogas H, Goldinger SM, Utikal J, Blank CU, Rauschenberg R, von Bubnoff D, Krackhardt A, Weide B, Haferkamp S, Kiecker F, Izar B, Garraway L, Regev A, Flaherty K, Paschen A, Van Allen EM, Schadendorf D (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nat Med. 2019;25(12):1916-1927.

Maron RC, Weichenthal M, Utikal JS, Hekler A, Berking C, Hauschild A, Enk AH, Haferkamp S, Klode J, Schadendorf D, Jansen P, Holland-Letz T, Schilling B, von Kalle C, Fröhling S, Gaiser MR, Hartmann D, Gesierich A, Kähler KC, Wehkamp U, Karoglan A, Bär C, Brinker TJ (2019)
Collaborators. Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks.
Eur J Cancer. 2019;119:57-65.

Menzer C, Menzies AM, Carlino MS, Reijers I, Groen EJ, Eigentler T, de Groot JWB, van der Veldt AAM, Johnson DB, Meiss F, Schlaak M, Schilling B, Westgeest HM, Gutzmer R, Pföhler C, Meier F, Zimmer L, Suijkerbuijk KPM, Haalck T, Thoms KM, Herbschleb K, Leichsenring J, Menzer A, Kopp-Schneider A, Long GV, Kefford R, Enk A, Blank CU, Hassel JC (2019)
Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.
J Clin Oncol. 2019;37(33):3142-3151.

Micossé C, von Meyenn L, Steck O, Kipfer E, Adam C, Simillion C, Morteza Seyed Jafari S, Olah P, Yawlkar N, Simon D, Borradori L, Kuchen S, Yerly D, Homey B, Conrad C, Snijder B, Schmidt M, Schlapbach C (2019)
Human “TH9” cells are a subpopulation of PPAR-+ TH2 cells.
Sci Immunol. 2019;4(31). pii: eaat5943. doi: 10.1126/sciimmunol.aat5943.

Mock A, Heilig CE, Kreutzfeldt S, Huebschmann D, Heining C, Schröck E, Brors B, Stenzinger A, Jäger D, Schlenk R, Glimm H, Fröhling S, Horak P (2019)
DKTK MASTER Network. Community-driven development of a modified progression-free survival ratio for precision oncology.
ESMO Open. 2019 Nov 13;4(6):e000583.
 

Nothhaft M, Klepper J, Kneitz H, Meyer T, Hamm H, Morbach H (2019)
Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature.
Front Pediatr. 2019; Jan 22:6:413.

Olk J, Hamm H, Bröcker EB, Goebeler M (2019)
Klinik für Dermatologie, Venerologie und Allergologie des Universitäts- klinikums Würzburg: Geschichte und Gegenwart.
Akt Dermatol. (2019) 45, 14-23.

Persa OD, Loquai C, Wobser M, Baltaci M, Dengler S, Kreuter A, Volz A, Laimer M, Emberger M, Doerler M, Mauch C, Helbig D (2019)
Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas.
J Eur Acad Dermatol Venereol. 2019;33(8):1577-1580.

Piperno-Neumann S, Piulats JM, Goebeler M, Galloway I, Lugowska I, Becker JC, VihinenP, Van Calster J, Hadjistilianou T, Proença R, Caminal JM, Rogasik M, Blay JY, Kapiteijn E (2019)
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer.
Cancers (Basel). 2019;11(6).

Rauschenberger T, Schmitt V, Azeem M, Klein-Hessling S, Murti K, Grän F, Goebeler M, Kerstan A, Klein M, Bopp T, Serfling E, Muhammad K (2019)
T Cells Control Chemokine Secretion by Keratinocytes.
Front Immunol. 2019;10:1917.

Röding K, Schrüfer P, Grän F, Olk J, Ueberschaar S, Behle V, Kneitz H, Goebeler M, Wobser M. (2019)
Kutane Lymphome – ein viel- gestaltiges Krankheitsbild.
Akt Dermatol. 2019;45, 52-59.

Russlies J, Fähnrich A, Witte M, Yin J, Benoit S, Gläser R, Günter C, Eming R, Erdmann J, Gola D, Gupta Y, Holtsche MM, Kern JS, König IR, Kiritsi D, Lieb W, Sadik CD, Sárdy M, Schauer F, van Beek N, Weidinger A, Worm M, Zillikens D, Schmidt E, Busch H, Ibrahim SM, Hirose M (2019)
Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
Front Immunol. 2019;10:2200. doi: 10.3389/fimmu.2019.02200.

Sánchez-Borges M, Aberer W, Brockow K, Celik GE, Cernadas J, Greenberger PA, Masse MS, Schrijvers R, Trautmann A (2019)
Controversies in Drug Allergy: Radiographic Contrast Media.
J Allergy Clin Immunol Pract. 2019;7, 61-65
.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R. (2019)
The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients.
Br J Dermatol. 2019;181(2):350-357.

Schilling B, Martens A, Geukes Foppen MH, Gebhardt C, Hassel JC, Rozeman EA, Gesierich A, Gutzmer R, Kähler KC, Livingstone E, Diamantopoulos PT, Gogas H, Madonna G, Ascierto PA, Goldinger SM, Mangana J, Garbe C, Schadendorf D, Blank C, Weide B (2019)
First-line therapy-stratified survival in BRAF-mutant melanoma: A retrospective multicenter analysis.
Cancer Immunol Immunother. 2019;68(5):765-772.

Schilling B, Wiesner T (2019)
Tackling melanoma by adjuvant therapy: why, whom and how?
Br J Dermatol. 2019;180, 1-2.

Schrama D, Sarosi EM, Adam C, Ritter C, Kaemmerer U, Klopocki E, König EM, Utikal J, Becker JC, Houben R (2019)
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
Int J Cancer. 2019 Aug 15; 145(4):1020-1032.

Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, French LE, Berking C, Schilling B, Haferkamp S, Fröhling S, von Kalle C, Brinker TJ (2019)
Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data.
Eur J Cancer. 2019 Sep;119:30-34.

Stepula E, König M, Wang XP, Levermann J, Schimming T, Kasimir-Bauer S, Schilling B, Schlücker S (2019)
Localization of PD-L1 on single cancer cells by iSERS microscopy with Au/Au core/satellite nanoparticles.
J Biophotonics. 2019;12:e201960034.

Stoevesandt J, Trautmann A (2019)
Bienen- und Wespengiftallergie in verschiedenen Lebensphasen.
Akt Dermatol. 2019;45, 24-31.

Stoevesandt J, Trautmann A (2019)
Lessons from times of shortage: Interchangeability of venom preparations and dosing protocols.
Allergy. 2019;74(7):1392-1395.

Sunderkötter C, Aebischer A, Neufeld M, Löser C, Kreuter A, Bialek R, Hamm H, Feldmeier H (2019)
Increase of scabies in Germany and development of resistant mites? Evidence and consequences.
J Dtsch Dermatol Ges. 2019;17(1):15-24.

Thiem A, Hesbacher S, Kneitz H, di Primio T, Heppt MV, Hermanns HM, Goebeler M, Meierjohann S, Houben R, Schrama D (2019)
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
J Exp Clin Cancer Res. 2019;38(1):397.

Tappenbeck N, Schröder HM, Niebergall-Roth E, Hassinger F, Dehio U, Dieter K, Kraft K, Kerstan A, Esterlechner J, Frank NY, Scharffetter-Kochanek K, Murphy GF, Orgill DP, Beck J, Frank MH, Ganss C, Kluth MA (2019)
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
Cytotherapy. 2019;21(5):546-560.

Trautmann A, Brockow K, Behle V, Stoevesandt J (2019)
Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation.
J Allergy Clin Immunol Pract. 2019;7(7):2218-2224.

Trautmann A, Stoevesandt J. (2019)
Differential diagnosis of late-type reactions to injected local anaesthetics: Inflammation at the injection site is the only indicator of allergic hypersensitivity.
Contact Dermatitis. 2019;80, 118-124.

Wobser M, Goebeler M (2019)
Cutaneous lymphomas : Clinical presentation - diagnosis - treatment.
Hautarzt. 2019;70(10):815-830.

Publikationen 2018

Adam C, Glück L, Ebert R, Goebeler M, Jakob F, Schmidt M. (2018) The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization. Bone 111, 49-58.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Pelz JOW. (2018) Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients. J Dermatolog Treat 29, 515-521.

Becker JC, Stang A, Hausen AZ, Fischer N, DeCaprio JA, Tothill RW, Lyngaa R, Hansen UK, Ritter C, Nghiem P, Bichakjian CK, Ugurel S, Schrama D. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67, 341-351.

Benoit S, Scheurlen M, Goebeler M, Stoevesandt J. (2018) Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement. Acta Derm Venereol 98, 660-666.

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. (2018) S2k Guidelines -Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86). J Dtsch Dermatol Ges 16, 112-122.

Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Odum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC. (2018)Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma. Clin Cancer Res 24, 5873-5882.

Fattouh K, Cunha N, Frings V, Hernandez-Aragues I, Stembridge N, Kuonen F. (2018) What's new this month? Eur J Dermatol 28, 134-135.

Frings A, Frings V, Geerling G, Goebeler M, Schargus M. (2018) Progrediente Ulzeration der Periorbita. Ophthalmologe 115, 157-160.

Frings V, Fattouh K, Hernandez Aragues I, Cunha N, Stembridge N, Kuonen F. (2018) What’s new this month? Eur J Dermatol 28, 278-279.

Frings VG, Böer-Auer A, Breuer K. (2018) Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. Am J Dermatopathol 40, 7-16.

Frings VG, Goebeler M, Kneitz H. (2018) Dermpath & Clinic: In situ melanoma arising within a speckled lentiginous nevus. Eur J Dermatol 28, 857-859.

Frings VG, Goebeler M, Wobser M. (2018) Dermpath & Clinic: Juvenile xanthogranuloma. Eur J Dermatol 28, 429-431.

Frings VG, Schäfer K, Strate A, Rosenwald A, Roth S, Kneitz H, Goebeler M, Geissinger E, Wobser M. (2018, in press) Paraproteinaemia in primary cutaneous marginal zone lymphoma. Acta Derm Venereol 98, 956-962.

Glossmann JP, Skoetz N, Starbatty B, Bischoff M, Leyvraz S, Westekemper H; AG SOP; Unter-AG Konjunktivales Melanom, Heindl LM (Collaborators: u. a. Gesierich A). (2018, in press) Conjunctival melanoma: Standard operating procedures in diagnosis, treatment and follow-up care. Ophthalmologe 115, 489-498.

Glutsch V, Gesierich A, Goebeler M, Forster J, Schilling B. (2018) Nocardiosis in a patient with with anti-PD-1-associated colitis treated with imnfliximab. Eur J Cancer 101, 284-286.

Goebeler M. (2018) Blasenbildende Autoimmunerkrankungen: zielgerichtete Diagnostik und multimodale Therapie. J Dtsch Dermatol Ges 16, 1071-1072.

Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S. (2018) Kinderwunsch bei Lupus erythematodes – eine medizinische Herausforderung. J Dtsch Dermatol Ges 16, 913-916.

Grimm J, Hufnagel A, Wobser M, Borst A, Haferkamp S, Houben R, Meierjohann S. (2018) BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1. Oncogenesis 7, 71.

Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, Gesierich G .(2018, in press) Pembrolizumab-associated Mucous Membrane Pemphigoid in a Merkel cell carcinoma patient. Brit J Dermatol 179, 993-994.

Haug V, Schilling B. (2018) Programmed death-1 blockade for multiple basal cell carcinomas: Clearing the field systemically? Brit J Dermatol 179, 566-567.

Heratizadeh A , Werfel T , Schubert S , Geier J ; IVDK ( Collaborators: u. a. Trautmann A). (2018) Contact sensitization in dental technicians with occupational contact dermatitis. Data of the Information Network of Departments of Dermatology (IVDK) 2001-2015. Contact Dermatitis 78, 266-273.

Herz C, Wirbelauer J, Hamm H. (2018) 4-jähriger Junge mit Fieber, generalisierter Rötung und Blasen. Hautarzt 69 (S2), 149-151.

Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E; BLISTER Study Group. (2018, in press) Prospective study in bullous pemphigoid: Association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. Br J Dermatol 179, 918-924.

Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A. (2018) A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell 175, 984-997.

Kähler KC, Eigentler TK, Gesierich A, Heinzerling L, Loquai C, Meier F, Meiss F, Pföhler C, Schlaak M, Terheyden P, Thoms KM, Ziemer M, Zimmer L, Gutzmer R; German Dermatologic Cooperative Oncology Group (DeCOG). (2018) Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders. Cancer Immunol Immunother 67, 825-834.

Kervarrec T, Gaboriaud P, Berthon P, Zaragoza J, Schrama D, Houben R, Le Corre Y, Hainaut Wierzbicka E, Aubin F, Bens G, Domenech J, Guyétant S, Touzé A, Samimi M. (2018) Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome. J Am Acad Dermatol. 78, 973-982.e8.

Kervarrec T, Samimi M, Gaboriaud P, Gheit T, Beby-Defaux A, Houben R, Schrama D, Fromont G, Tommasino M, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Maillard H, Furudoï A, Michenet P, Touzé A, Guyétant S. (2018) Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinoma. Virchows Arch 472, 825-837.

Kirchberger MC, Schilling B, Haferkamp S, Bosserhoff A, Schuler G, Heinzerling L. (2018) Can checkpoint inhibitor therapy improve response to chemotherapy? J Cancer Res Clin Oncol 144, 183-185.

Kneitz H, Fetzer S, Goebeler M, Bröcker EB. (2018) Differenzialdiagnostische Bedeutung epithelialer und stromaler CD10-Expression in Tumoren trichogenen Ursprungs. J Dtsch Dermatol Ges 16, 719-729.

Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT. (2018) Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res 24, 5347-5356.

Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2018) Panel Sequencing Reveals Recurrent Genetic FAS Alterations. In Primary Cutaneous Marginal Zone Lymphoma. J Invest Dermatol 138, 1573-1581.

Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM; Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, Signoretti S, Sholl LM; Engelman JA, Getz G, Jänne PA, Haddad RI, Choueiri TK, Barbie DA; Haq R, Awad MM; Schadendorf D, Hodi FS, Bellmunt J, Wong KK; Hammerman P, Van Allen EM. (2018, in press) Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nature Genet 50, 1271-1281.

Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B. (2018) Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade. Eur J Cancer 99, 58-65.

Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, Seifert U, Sucker A, Lennerz V, Wölfel T, Schadendorf D, Schilling B, Paschen A, Zhao F. (2018) Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment. Oncoimmunology Apr 18;7(8):e1450127. doi: 10.1080/2162402X.2018.1450127.

Recke A, Konitzer S, Lemcke S, Freitag M, Sommer NM, Abdelhady M, Amoli MM, Benoit S, El-Chennawy F, Eldarouti M, Eming R, Gläser R, Günther C, Hadaschik E, Homey B, Lieb W, Peitsch WK, Pföhler C, Robati RM, Saeedi M, Sárdy M, Sticherling M, Uzun S, Worm M, Zillikens D, Ibrahim S, Vidarsson G, Schmidt E; German AIBD Genetic Study Group. (2018) The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts. Front Immunol  Aug 2;9:1788. doi: 10.3389/fimmu.2018.01788.

Reichel A, Goebeler M, Weyandt G. (2018) Perforierender Nasenwanddefekt: Verschluss mittels Kombinationslappenplastik. J Dtsch Dermatol Ges 16, 1399-1401.

Sander D, Dietmeier W, Wobser M, Haferkamp S. (2018) Hyperkeratose der Brustwarze und des Warzenhofs: eine histologische Falle! J Dtsch Dermatol Ges 16, 1368-1371

Schäfer K, Cotofana S, Goebeler M, Weyandt G. (2018, in press) Large nasal defects with exposed cartilage: The folded transposition flap. Dermatology 31, 1-16.

Schmid C, Reichel A, Kerstan A, Gesierich A, Hamm H. (2018) Slate-gray macules in the axillae. Hautarzt 69, 177-179.

Schmid FF, Groeber-Becker F, Schwab S, Thude S, Goebeler M, Walles H, Hansmann J. (2018) A standardized method based on pigmented epidermal models evaluates sensitivity against UV-irridation. ALTEX 35, 390-396.

Schmidt M, Goebeler M. (2018) Innate Immune System response in Metal Allergy: Toll-Like Receptors. In: Chen JK, Thyssen J (Hrg.): Metal Allergy. From Dermatitis to Implant and device Failure. Springer-Verlag, Berlin-Heidelberg-New York S. 75-84.

Scholz S, Cosgarea I, Süßkind D, Murali R, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker S, Steuhl KP, Schadendorf D, Westekemper H, Griewank K, Möller I. (2018) NF1 mutations in conjunctival melanoma. Brit J Cancer 118, 1243-1247.

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ. (2018) Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. Cell 173, 624-633.e8.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A. (2018) Sensitization to Hymenoptera Venom Marker Allergens: Prevalence, Predisposing Factors, and Clinical Implications. Clin Exp Allergy 48, 1735-1743.

Stoevesandt J, Trautmann A. (2018) Freshly squeezed: anaphylaxis caused by drone larvae juice. Eur Ann Allergy Clin Immunol 50, 232-234.

Stolze I, Hamm H. (2018) Lichen nitidus and lichen striatus. Hautarzt 69, 121-126.

Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tüting T, Ulrich C, Wollina U, Hassel JC, Gutzmer R, Goerdt S, Zouboulis C, Leiter U, Eigentler TK, Garbe C. (2018) Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Brit J Dermatol 178, 443-451.

Thiem A, Schummer P, Ueberschaar S, Kerstan A, Kneitz H, Schrama D, Appenzeller S, Meierjohann S, Schilling B, Goebeler M, Gesierich A. (2018, in press) Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors. Melanoma Res 28, 465-468.

Trautmann A, Goebeler M, Stoevesandt J. (2018) Twenty years' experience with anaphylaxis-like reactions to local anesthetics: genuine allergy is rare. J Allergy Clin Immunol Pract 6, 2051-2058.e1.

Vogt T, Goebeler M. (2018) Lichenoid diseases. Hautarzt 69, 98-99.

Publikationen 2017

Adam C, Wohlfarth J, Haußmann M, Sennefelder H, Rodin A, Maler M, Martin SF, Goebeler M, Schmidt M. (2017) Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation. J Invest Dermatol 137, 367-376.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Gasser M, Pelz JOW. (2017) Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients. World J Surg Oncol 15:99.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Pelz JOW. (2017) Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients. J Dermatolog Treat 16:1-7. doi: 10.1080/09546634.2017.1398395.

Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pföhler C, Kellner I, Meier F, Kähler K, Mohr P, Berking C, Haas G, Helwig C, Oksen D, Schadendorf D, Mahnke L, Bharmal M. (2017) Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe. Oncotarget 8(45):79731-79741 doi: 10.18632/oncotarget.19218.

Behle V, von Braunmühl T, Sayehli C, Gesierich A, Goebeler M, Geissinger E, Wobser M. (2017) Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis. Acta Derm Venereol 97, 973-975.

Borst A, Haferkamp S, Grimm J, Rösch M, Zhu G, Guo S, Li C, Gao T, Meierjohann S, Schrama D, Houben R. (2017 in press) BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines. Cancer Letters Letters 404, 70-78.

Cunha N, Fattouh K, Frings V, Hernandez-Aragues I, Stembridge N, Kuonen F. (2017) What’s new this month? Eur J Dermatol 27, 678-679.

Cunha N, Stembridge N, Frings V, Fattouh K, Hernandez-Aragues I, Kuonen F. (2017) Editorial: What's new this month? Eur J Dermatol 27, 446-447.

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. (2017) S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86). J Dtsch Dermatol Ges 15, 1266-1273.

Dogliotti G, Kullmann L, Dhumale P, Thiele C, Panichkina O, Mendl G, Houben R, Haferkamp S, Püschel AW, Krahn MP. (2017) Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression. Nat Commun 8:15747 doi:10.1038/ncomms15747.

Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, Livingstone E, Zimmer L, Schmid KW, Dittmer U, Schadendorf D, Schilling B. (2017) Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. Eur J Cancer 86, 248-256.

Frings A, Frings V, Geerling G, Goebeler M, Schargus M. (2017, in press) Progrediente Ulzeration der Periorbita. Ophthalmologe, doi:10.1007/s00347-017-0512-0.

Frings V, Fattouh K, Hernandez-Aragues I, Cunha N, Stembridge N, Kuonen F. (2017) Editorial: What's new this month? Eur J Dermatol 27, 214-215.

Frings VG, Böer-Auer A, Breuer K. (2017, in press) Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. Am J Dermatopathol.

Frings VG, Goebeler M, Kneitz H. (2017) Dermpath & Clinic: Giant trichoblastoma of the leg. Eur J Dermatol 27, 447-448.

Frings VG, Hamm H. (2017) Dermatologische Manifestationen der tuberösen Sklerose (TSC) (Leserbrief zu Ebrahimi-Fakhari D et al., J Dtsch Dermatol Ges 15, 695-701). J Dtsch Dermatol Ges 15, 1155-1156.

Frings VG, Roth S, Riedmiller AL, Schäfer K, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2017) Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20. Acta Derm Venereol 97, 534-536.

Frings VG, Trautmann A, Goebeler M, Wobser M. (2017) Dermpath & Clinic: Multiple reactive eccrine syringofibroadenomas. Eur J Dermatol 27, 102-104.

Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Eckhard Fiedler E, Gerold Schuler G, Ulrike Leiter U, Weide B, Grischke EM, Martus P, Garbe C. (2017) Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry. J Invest Dermatol 137, 2570-2577.

Giner T, Benoit S, Kneitz H, Goebeler M. (2017, in press) Sarkoidose – der dermatologische Blick auf eine seltene Multisystemerkrankung. Hautarzt 68, 526-535.

Griewank KG, Müller H, Jackett LA, Emberger M, Möller I, van de Nes JA, Zimmer L, Livingstone E, Wiesner T, Scholz SL, Cosgarea I, Sucker A, Schimming T, Hillen U, Schilling B, Paschen A, Reis H, Mentzel T, Kutzner H, Rütten A, Murali R, Scolyer RA, Schadendorf D. (2017, in press) SF3B1 and BAP1 mutations in blue nevus-like melanoma. Mod Pathol 30, 928-939.

Griewank KG, Paschen A. (2017) Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nat Commun 8:15440 doi:10.1038/ncomms15440.

Gutzmer R, Koop A, Meier F, Hassel JC, Terheyden P, Zimmer L, Heinzerling L, Ugurel S, Pföhler C, Gesierich A, Livingstone E, Satzger I, Kähler KC; German Dermatooncology Group (DeCOG). (2017) Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity. Eur J Cancer 75, 24-32.

Hamm H. (2017) Krätzealarm im Altenheim. MMW Fortschr Med 159, 22.

Haug V, Benoit S, Wohlleben M, Hamm H. (2017, in press) Annular pustular psoriasis in a 14-month-old girl: a therapeutic challenge. J Dermatolog Treat 28, 520-522.

Haymerle G, Janik S, Fochtmann A, Pammer J, Schachner H, Nemec L, Mildner M, Houben R, Grasl MC, Erovic BM. (2017) Expression of Merkel cell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome. PLoS One Aug 1;12(8):e0180426. doi: 10.1371/journal.pone.0180426.

Helbig D, Quaas A, Mauch C, Merkelbach-Bruse S, Büttner R, Emberger M, Wobser M, Rüsseler V, Pütz K, Binot E, Rehker J, Budczies J, Ihle MA. (2017) Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget 8, 109457-109467.

Heppt MV, Siepmann T, Engel J, Schubert-Fritschle G, Eckel R, Mirlach L, Kirchner T, Jung A, Gesierich A, Ruzicka T, Flaig MJ, Berking C. (2017) Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC Cancer Aug 10;17(1):536. doi: 10.1186/s12885-017-3529-5.

Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C. (2017) Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer 81, 36-44.

Hernandez-Aragues I, Cunha N, Fattouh K, Frings V, Stembridge N, Kuonen F. (2017) What's new this month? Eur J Dermatol 27, 335-336.

Hosp C, Hamm H. (2017, in press) Safety of available and emerging drug therapies for hyperhidrosis. Exp Opin Drug Safety 16, 1039-1049.

Improta G, Ritter C, Pettinato A, Vasta V, Schrama D, Fraggetta F, Becker JC. (2017, in press) MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus in vivo. J Cancer Res Clin Oncol 143, 1489-1497.

Khalil AA, Ilina O, Gritsenko PG, Bult P, Span PN, Friedl P. (2017) Collective invasion in ductal and lobular breast cancer associates with distant metastasis. Clin Exp Metastasis 34, 421-429.

M.B. Faries, J.F. Thompson, A.J. Cochran, R.H. Andtbacka, N. Mozzillo, J.S. Zager, T. Jahkola, T.L. Bowles, A. Testori, P.D. Beitsch, H.J. Hoekstra, M. Moncrieff, C. Ingvar, M.W.J.M. Wouters, M.S. Sabel, E.A. Levine, D. Agnese, M. Henderson, R. Dummer, C.R. Rossi, R.I. Neves, S.D. Trocha, F. Wright, D.R. Byrd, M. Matter, E. Hsueh, A. MacKenzieRoss, D.B. Johnson, P. Terheyden, A.C. Berger, T.L. Huston, J.D. Wayne, B.M. Smithers, H.B. Neuman, S. Schneebaum, J.E. Gershenwald, C.E. Ariyan, D.C. Desai, L. Jacobs, K.M. McMasters, A. Gesierich, P. Hersey, S.D. Bines, J.M. Kane, R.J. Barth, G. McKinnon, J.M. Farma, E. Schultz, S. Vidal‐Sicart, R.A. Hoefer, J.M. Lewis, R. Scheri, M.C. Kelley, O.E. Nieweg, R.D. Noyes, D.S.B. Hoon, H. J. Wang, D.A. Elashoff, and R.M. Elashoff. (2017) Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. New Engl J Med 376, 2211-2222.

Mergler R, Kerstan A, Schmidt E, Goebeler M, Benoit S. (2017) Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature. Case Rep Dermatol 9, 121–130.

Mindorf S, Dettmann IM, Krüger S, Fuhrmann T, Rentzsch K, Karl I, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, Sárdy M, Bangert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman MF, Stöcker W, Schmidt E, International Autoimmune Bullous Diseases Study Group. (2017) Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical Pemphigus. Exp Dermatol 26, 1267-1270.

Müller-Richter UDA, Gesierich A, Kübler AC, Hartmann S, Brands RC. (2017) Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment. Ann Surg Oncol 24, 3430-3427.

Ofner R, Ritter C, Heidenreich B, Kumar R, Ugurel S, Schrama D, Becker JC. (2017) Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. J Cancer Res Clin Oncol 143, 613-617.

Ofner R, Ritter C, Ugurel S, Cerroni L, Stiller M, Bogenrieder T, Solca F, Schrama D, Becker JC. (2017) Non-reproducible sequence artifacts in FFPE tissue: an experience Report. J Cancer Res Clin Oncol 143, 1199-1207.

Oji V, Preil ML, Kleinow B, Wehr G, Fischer J, Hennies HC, Hausser I, Breitkreutz D, Aufenvenne K, Stieler K, Tantcheva-Poór I, Weidinger S, Emmert S, Hamm H, Perusquia-Ortiz AM, Zaraeva I, Diem A, Giehl K, Fölster-Holst R, Kiekbusch K, Höger P, Ott H, Traupe H. (2017) S1 guidelines for the diagnosis and treatment of ichthyoses – update. J Dtsch Dermatol Ges 15, 1053-1065.

Papapanagiotou M, Griewank KG, Hillen U, Schimming TT, Moeller LC, Führer D, Zimmer L, Roesch A, Sucker A, Schadendorf D, Livingstone E, Schilling B. (2017) Trametinib-Induced Remission of an MEK1-Mutated Langerhans Cell Histiocytosis. JCO Precision Oncology doi: 10.1200/PO.16.00070.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M2 and the ALCANZA study group (Collaborators: Trotman J, Joske D, Prince HM, Taylor K, Lewis ID, Jonak C, Trautinger F, Bechter O, Wolter P, Bron D, de Lima VCC, Sanches JA Junior, Klasa R, Bagot M, Beylot-Barry M, Dalle S, D'Incan M, Dreno B, Grange F, Nicolay J, Stadler R, Weichenthal M, Wobser M, Assaf C, Loquai C, Quaglino P, Spina M, Zinzani PL, Bosi A, Fattori PP, Grzanka A, Walewski J, Lopez-Hernandez A, Ortiz-Romero PL, Roca JJR, Canales SN, Dummer R, Illidge T, Johnson R, Whittaker S, Morris S, McKay P, Scarisbrick J, Duvic M, Feldman T, Akilov O, Geskin L, Horwitz S, Kim YH, Pro B, Kuzel T, Lerner A, Eradat H, Sokol L, Fisher DC, Hughey S). (2017) Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet 390, 555-566.

Reichel A, Benoit S, Giner T, Schmidt E, Goebeler M, Stoevesandt J. (2017) Anti-Desmoglein 1 IgG/IgA-Pemphigus in Verbindung mit einem Thymom. J Dtsch Dermatol Ges 15, 1147-1149.

Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B. (2017) Kaposiformes Hämangioendotheliom mit Kasabach-Merritt-Syndrom: erfolgreiche Therapie mit Sirolimus. J Dtsch Dermatol Ges 15, 329-331.

Ritter C, Fan K, Paschen A, Reker Hardrup S, Ferrone S, Nghiem P, Ugurel S, Schrama D, Becker JC. (2017) Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Sci Rep 7(1):2290. doi:10.1038/s41598-017-02608-0.

Sadik CD, Bischof J, van Beek N, Dieterich A, Benoit S, Sárdy M, Worm M, Meller S, Gläser R, Zillikens D, Homey B, Setterfield J, Minassian D, Schmidt E, Dart J; MMP study group 2009 - 2014; Autoimmune Bullous Diseases Study Group, Ibrahim SM. (2017) Genome-wide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid. Exp Dermatol 26, 2014-2020.

Sadik CD, Pas HH, Bohlmann MK, Mousavi S, Benoit S, Sárdy M, Terra JB, Lima AL, Hammers CM, van Beek N, Bangert C, Zillikens D, Schmidt E. (2017) Value of BIOCHIP Technology in the Serological Diagnosis of Pemphigoid Gestationis. Acta Derm Venereol 97, 128-130.

Schäfer K, Bauer B, Donhauser J, Kerstan A, Hamm H. (2017) Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature. Acta Derm Venereol 97, 499-504.

Schmidt E, Benoit S, Kampik D, Hille K, Geerling G. (2017) Tibial bone keratoprosthesis: reversing blindness in mucous membrane pemphigoid. J Dtsch Dermatol Ges 15, 1024-1026.

Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M. (2017, in press) Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita - a multicenter analysis. Brit J Dermatol.

Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M. (2017) Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita - a multicenter analysis. Brit J Dermatol 177, 1683-1692.

Scholz SL, Möller I, Reis H, Süßkind D, van de Nes JAP, Leonardelli S, Schilling B, Livingstone E, Schimming T, Paschen A, Sucker A, Murali R, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG. (2017) Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. Invest Ophthalmol Vis Sci 58, 3464-3470.

Schrama D, Ritter C, Becker JC. (2017) T cell receptor repertoire usage in cancer as a surrogate marker for immune Responses. Semin Immunopathol 39, 255-268.

Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A; ERIVANCE BCC Investigators. (2017) Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 17, 332. doi:10.1186/s12885-017-3286-5.

Stembridge N, Cunha N, Frings V, Fattouh K, Hernandez-Aragues I, Kuonen F. (2017) Editorial: What's new this month? Eur J Dermatol 27, 565-566.

Sticherling M, Franke A, Aberer E, Gläser R, Hertl M, Pfeiffer C, Rzany B, Schneider S, Shimanovich I, Werfel T, Wilczek A, Zillikens D, Schmidt A. (2017) An open, multicenter, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. Brit J Dermatol 177, 1299-1305.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A. (2017) Safety of 100 µg venom immunotherapy rush protocols in children compared to adults. Allergy Asthma Clin Immunol 13:32 doi: 10.1186/s13223-017-0204-y.

Sucker A, Zhao F, Pieper N, Heeke C, Maltaner R, Stadtler N, Real B, Bielefeld N, Howe S, Weide B, Gutzmer R, Utikal J, Loquai C, Gogas H, Klein-Hitpass L, Zeschnigk M, Westendorf AM, Trilling M, Horn S, Schilling B, Schadendorf D, Griewank KG, Paschen A. (2017) Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nat Commun 8:15440 doi:10.1038/ncomms15440.

Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tüting T, Ulrich C, Wollina U, Hassel JC, Gutzmer R, Goerdt S, Zouboulis C, Leiter U, Eigentler TK, Garbe C. (2017, in press) Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Brit J Dermatol.

Thiem A, Kneitz H, Schummer P, Herz S, Schrama D, Houben R, Goebeler M, Schilling B, Gesierich A. (2017) Coincident metastatic melanoma and Merkel cell carcinoma with complete remission upon treatment with pembrolizumab. Acta Derm Venereol 97, 1252-1254.

Toksoy A, Sennefelder H, Adam C, Hofmann S, Trautmann A, Goebeler M, Schmidt M. (2017) Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir. J Biol Chem 292, 2805-2814.

Toksoy A, Strifler S, Benoit S, Grigoleit GU, Knop S, Mielke S, Buder-Bakhaya K, Roth S, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2017) Facial Swelling and Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr Virus-associated T-cell Lymphoproliferation with Subsequent Development of Lymphoma. Acta Derm Venereol 97, 379-380.

Trautmann A, Benoit S, Goebeler M, Stoevesandt J. (2017, in press) "Treating Through" Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas. J Allergy Clin Immunol Pract 5, 1650-1656.

Trautmann A, Stoevesandt J. (2017) Reply. J Allergy Clin Immunol Pract 5, 535-536.

Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC. (2017) Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial. Oncotarget 8, 76029-76043 doi: 10.18632/oncotarget. 18635.

Walter E, Vielmuth F, Rotkopf L, Sárdy M, Horváth ON, Goebeler M, Schmidt E, Eming R, Hertl M, Spindler V, Waschke J. (2017) Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Sci Rep 7(1):3579. doi:10.1038/s41598-017-03697-7.

Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, Chapman A, Whitham D, Nunn AJ; UK Dermatology Clinical Trials Network BLISTER Study Group (Collaborators: u. a. Bröcker EB). (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled Trial. Lancet 389, 1630-1638.

Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A, Geissinger E. (2017) MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype. Br J Dermatol 177, 564-566.

Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak L, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R on behalf oft he EHSF Investigator Group. (2017) Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity. Br J Dermatol 177, 1401-1409.

 

 

Publikationen 2016

Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M. (2016) Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis. Int Arch Allergy Immunol 171, 141-154.

Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E. (2016) NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nat Commun 7, 11724.

Basmanav FB, Cau L, Tafazzoli A, Méchin MC, Wolf S, Romano MT, Valentin F, Wiegmann H, Huchenq A, Kandil R, Garcia Bartels N, Kilic A, George S, Ralser DJ, Bergner S, Ferguson DJ, Oprisoreanu AM, Wehner M, Thiele H, Altmüller J, Nürnberg P, Swan D, Houniet D, Büchner A, Weibel L, Wagner N, Grimalt R, Bygum A, Serre G, Blume-Peytavi U, Sprecher E, Schoch S, Oji V, Hamm H, Farrant P, Simon M, Betz RC. (2016) Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome. Am J Hum Genet 99, 1292-1304.

Behle V, Goebeler M, Gesierich A. (2016) Seriously saRComa: Neurofibrosarcoma. Eur J Dermatol 26, 517-518.

Behle V, Wobser M, Goebeler M, Stoevesandt J. (2016) Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod. Mult Scler 22, 969-71.

Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K. (2016) Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes. Eur J Nucl Med Mol Imaging 43, 2304-2312.

Bröcker E, Gollnick H, Goerdt S, Malte-Baron J. (2016) Obituary: Professor Martin Leverkus: 1965-2016. Br J Dermatol 174, 1424-1245.

Bröcker E, Gollnick H, Goerdt S, Baron JM. (2016) Martin Leverkus – Nachruf. J Dtsch Dermatol Ges 14, 459-61.

Dieckmann R, Boone I, Brockmann SO, Hammerl JA, Kolb-Mäurer A, Goebeler M, Luch A, Dahouk SA. (2016) Risiken für bakterielle Infektionen nach Tätowierungen. Ein systematisches Literaturreview. Dtsch Arztebl Int 113, 665-71.

Ellerbroek V, Hamm H. (2016) Pityriasis Lichenoides et Varioliformis Acuta: Remission with Hypopigmentation. J Pediatr 176, 211-211.

Hamm H. (2016) Kinderdermatologie: ein Kleinod unseres Fachgebiets. J Dtsch Dermatol Ges 14, 345-6.

Hamm H. (2016) Severely impaired quality of life. "My sweating is intolerable.". MMW Fortschr Med 158, 46-50.

Hesbacher S, Pfitzer L, Wiedorfer K, Angermeyer S, Borst A, Haferkamp S, Scholz CJ, Wobser M, Schrama D, Houben R. (2016) RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells. Oncotarget 7, 32956-32968.

Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Thomas J, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. (2016) Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur J Cancer 60, 190-209.

Hosp C, Naumann MK, Hamm H. (2016) Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea. Semin Neurol 36, 20-8.

Karademir F, Rose C, Goebeler M, Kneitz H, Hamm H, Wobser M. (2016) Multiple eruptive Angiofibrome bei einem 14-jährigen Mädchen. J Dtsch Dermatol Ges 14, 746-748.

Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, Goebeler M, Prelog M. (2016) Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity 25, 1-15.

Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S. (2016) Interactions of donor sources and media influence the histomorphological quality of full-thickness skin models. Biotechnol J 11, 1352-1361.

Lengfeld J, Buder-Bakhaya K, Goebeler M, Wobser M. (2016) Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions. Dermatology 232, 117-121.

Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174, 514-521.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N, German Network for Systemic Scleroderma (2016) Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients. J Rheumatol 43, 66-74.

Müller-Richter UD, Weyandt GH, Woeckel A, Kübler AC. (2016) Vermilion Reconstruction with Genital Mucosa. Plast Reconstr Surg Glob Open 4(5):e701.

Nicolay JP, Wobser M. (2016) Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges 14, 1207-1224.

Ochsendorf F, Bandholz T, Emmert S, Hartmann K, Hartmann M, Hornung T, Jünger M, Kollewe T, Löser C, Moll I, Psotta-Schachtner C, Spornraft-Ragaller P, Ständer S, von Stebut-Borschitz E, Hamm H. (2016) 111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen Gesellschaft. J Dtsch Dermatol Ges 14, 637-43.

Ritter C, Fan K, Paulson KG, Nghiem P, Schrama D, Becker JC. (2016) Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep 6, 21678.

Schmidt M, Goebeler M, Martin SF. (2016) Methods to Investigate the Role of Toll-Like Receptors in Allergic Contact Dermatitis. Methods Mol Biol 1390, 319-40.

Schrama D, Hesbacher S, Angermeyer S, Schlosser A, Haferkamp S, Aue A, Adam C, Weber A, Schmidt M, Houben R. (2016) Serine 220 phosphorylation of the Merkel cell polyomavirus Large T antigen crucially supports growth of Merkel cell carcinoma cells. Int J Cancer 138, 1153-62.

Stolze I, Trautmann A, Goebeler M, Stoevesandt J. (2016) Dangerous Leg Cramps: Severe Pustular Exanthema Caused by an Over-the-Counter Drug. Acta Derm Venereol 96, 703-704.

Sunderkötter C, Feldmeier H, Fölster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. (2016) S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung. J Dtsch Dermatol Ges 14, 1160-1171.

Thiem A, Kütt S, Hamm H. (2016) 'Television alopecia': a rare cause of pressure alopecia. J Eur Acad Dermatol Venereol 30, 504-505.

Thiem A, Mergler R, Kneitz H, Weyandt G, Goebeler M, Gesierich A. (2016) Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy. J Dtsch Dermatol Ges 14, 427-8.

Thomas AC, Zeng Z, Rivière JB, O'Shaughnessy R, Al-Olabi L, St-Onge J, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E, Chiaverini C, Chong WK, Duffourd Y, Glover M, Groesser L, Hadj-Rabia S, Hamm H, Happle R, Mushtaq I, Lacour JP, Waelchli R, Wobser M, Vabres P, Patton EE, Kinsler VA. (2016) Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 136, 770-8.

Trautmann A, Anders D, Stoevesandt J. (2016) H1-Antihistamine Premedication in NSAID-Associated Urticaria. J Allergy Clin Immunol Pract 4, 1205-1212.

Trautmann A, Seidl C, Stoevesandt J, Seitz CS. (2016) General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy 46, 125-32.

Wiedemann K, Schmid C, Hamm H, Wirbelauer J. (2016) Staphylococcal Scalded Skin Syndrome in a Very Low Birth Weight Premature Infant. Z Geburtshilfe Neonatol 220, 25-8.

Willmes C, Kumar R, Becker JC, Fried I, Rachakonda PS, Poppe LM, Hesbacher S, Schadendorf D, Sucker A, Schrama D, Ugurel S. (2016) SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma. Oncotarget 7, 10117-32.

Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. (2016) Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncol Ther 4, 199-210.

Zhu G, Yi X, Haferkamp S, Hesbacher S, Li C, Goebeler M, Gao T, Houben R, Schrama D. (2016) Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells. Cancer Lett 376, 43-52.

Ziegler W, Lempert S, Goebeler M, Kolb-Mäurer A. (2016) Tinea capitis: Erregerspektrum und Epidemiologie im zeitlichen Wandel. J Dtsch Dermatol Ges 14, 818-26.

Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, Gutzmer R, Utikal JS,  Göppner D, Hassel JC, Meier F, Tietze JK, Forschner A, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentlicher T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. (2016) Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 60, 210-25.

Publikationen 2015

Bauer B, Trautmann A (2015)
Swollen Ears and Nose Bleeding Accompanied by Skin Papules.
Pediatr Dermatol 32, 863-4.

Bauer B, Goebeler M, Weissbrich B, Kerstan A (2015)
Kerinokeratosis Papulosa of Childhood.
Dermatology 231, 1-4.

Behle V, Goebeler M (2015)
Residents'corner April 2015. Seriously saRComa!: Dermatofibrosarcoma protuberans.
Eur J Dermatol 25, 214.

Behle V, Kneitz H, Goebeler M (2015)
Residents' corner October 2015. Seriously saRComa!: Atypical fibroxanthoma.
Eur J Dermatol 25, 520-1.

Benoit S, Goebeler M (2015)
Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful?
Acta Derm Venereol 95, 596-9.

Benoit S, Hamm H (2015)
Differenzialdiagnose erosiver und ulzeröser Mundschleimhauterkrankungen im Kindesalter.
Hautarzt 66, 258-66.

Brenner I, Roth S, Flossbach L, Wobser M, Rosenwald A, Geissinger E (2015)
Lack of MYD88 L265P Mutation in Primary Cutaneous Marginal Zone Lymphoma.
Brit J Dermatol 173, 1527-1528.

Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF (2015)
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM).
Allergo J Int 24, 94-105.

Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group (Kollaboratoren: u. a. Benoit S) (2015)
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
Br J Dermatol 173, 227-34.

Erfle H, Pashayeva K, Harder N, Zhang L, Rohr K, Schadendorf D, Ugurel S, Keese M (2015)
Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes.
Biotechnol J 10, 1467-77.

Florence ME, Massuda JY, Soares TC, Stelini RF, Poppe LM, Bröcker EB, Metze K, Cintra ML, de Souza EM (2015)
p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation.
Pathol Res Pract 211, 782-8.

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators (Kollaboratoren: u. a. Benoit S) (2015)
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Lancet 386, 541-51.

Hamm H, Höger PH (2015)
Nachwuchsprobleme.
Hautarzt 66, 234-35.

Hill R, Kalathur RK, Colaço L, Brandão R, Ugurel S, Futschik M, Link W (2015)
TRIB2 as a biomarker for diagnosis and progression of melanoma.
Carcinogenesis 36, 469-77.

Hirose M, Schilf P, Benoit S, Eming R, Gläser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pföhler C, Sárdy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM; German AIBD Genetic Study Group (2015)
Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population.
Exp Dermatol 24, 715-7.

Höger PH, Hamm H (2015)
Psoriasis vulgaris bei Kindern und Jugendlichen.
Hautarzt 66, 267-76.

Houben R, Angermeyer S, Haferkamp S, Aue A, Goebeler M, Schrama D, Hesbacher S (2015)
Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.
Int J Cancer 136, E290-300.

Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM (2015)
Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
Exp Dermatol 24, 663-8.

Kneitz H, Mentzel T, Wobser M, Goebeler M (2015)
Kutanes PECom des rechten Unterschenkels.
JDDG 13, 815-7.

Kneitz H, Motschenbacher S, Wobser M, Goebeler M (2015)
Photoletter to the editor: Giant cutaneous horn associated with squamous cell carcinoma.
J Dermatol Case Rep 9, 27-8.

Kneitz H, Wobser M, Stoevesandt J, Goebeler M (2015)
Therapieresistente purulente Papeln und Knoten gluteal und im Bereich beider Oberschenkel.
Hautarzt 66, 636-8.

Kolb-Mäurer A, Goebeler M, Mäurer M (2015)
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Int J Mol Sci 16, 14951-60.

Komaravolu RK, Adam C, Moonen JR, Harmsen MC, Goebeler M, Schmidt M (2015)
Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
Cardiovasc Res 105, 86-95.

Leikam C, Hufnagel AL, Otto C, Murphy DJ, Mühling B, Kneitz S, Nanda I, Schmid M, Wagner TU, Haferkamp S, Bröcker EB, Schartl M, Meierjohann S (2015)
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.
Cell Death Dis 6:e1711.

Lengfeld J, Kneitz H, Goebeler M, Kolb-Mäurer A (2015)
Panniculitis due to pancreatic disease.
JDDG 13, 807-9.

Moonen JR, Lee ES, Schmidt M, Maleszewska M, Koerts JA, Brouwer LA, van Kooten TG, van Luyn MJ, Zeebregts CJ, Krenning G, Harmsen MC (2015)
Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.
Cardiovasc Res 108, 377-86.

Mössner R, Zimmer L, Berking C, Hoeller C, Loquai C, Richtig E, Kähler KC, Hassel JC, Gutzmer R, Ugurel S (2015)
Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature.
J Eur Acad Dermatol Venereol 29, 1797-806.

Odongo L, Mulyowa G, Goebeler M, Trautmann A (2015)
Bet v 1- and Bet v 2-Associated Plant Food Sensitization in Uganda and Germany: Differences and Similarities.
Int Arch Allergy Immunol 167, 264-269.

Poppe H, Kerstan A, Böckers M, Goebeler M, Geissinger E, Rosenwald A, Hamm H (2015)
Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype.
J Cutan Pathol 42, 258-64.

Recke A, Vidarsson G, Ludwig RJ, Freitag M, Möller S, Vonthein R, Schellenberger J, Haase O, Görg S, Nebel A, Flachsbart F, Schreiber S, Lieb W, Gläser R, Benoit S, Sárdy M, Eming R, Hertl M, Zillikens D, König IR, Schmidt E, Ibrahim S; German AIBD Genetic Study Group. Collaborators (18) Benoit S, Däschlein G, Eming R, Gläser R, Goebeler M, Goetze S, Günther C, Hadaschik E, Homey B, Hunzelmann N, Kreuter A, Kunz M, Lippert U, Ludwig-Peitsch W, Pföhler C, Sárdy M, Sticherling M, Worm M (2015)
Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases.
J Autoimmun 61, 36-44.

Schmidt M, Goebeler M (2015)
Immunology of metal allergies.
JDDG 13, 653-9.

Schmieder A, Poppe M, Hametner C, Meyer-Schraml H, Schaarschmidt ML, Findeisen P, Benoit S, Bauer B, Schmid S, Goebeler M, Goerdt S, Ludwig-Peitsch WK (2015)
Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
Arch Dermatol Res 307, 413-24.

Sommer M, Trautmann A, Stoevesandt J (2015)
Relief of photoallergy: atorvastatin replacing simvastatin.
J Investig Allergol Clin Immunol 25, 138-40.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A (2015)
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective.
Ann Allergy Asthma Immunol 114, 411-6.

Teichert M, Stumpf C, Booken N, Wobser M, Nashan D, Hallermann C, Mogler C, Müller CS, Becker JC, Moritz RK, Andrulis M, Nicolay JP, Goerdt S, Thomas M, Klemke CD, Augustin HG, Felcht M (2015)
Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis.
Exp Dermatol 24, 424-9.

Thode C, Woetmann A, Wandall HH, Carlsson MC, Qvortrup K, Kauczok CS, Wobser M, Printzlau A, Odum N, Dabelsteen S (2015)
Malignant T Cells Secrete Galectins and Induce Epidermal Hyperproliferation and Disorganized Stratification in a Skin Model of Cutaneous T Cell Lymphoma.
J Invest Dermatol 135, 238-246.

Ugurel S, Loquai C, Kähler K, Hassel J, Berking C, Zimmer L, Haubitz I, Satzger I, Müller-Brenne T, Mikhaimer NC, Becker JC, Kilian KJ, Schadendorf D, Heinzerling L, Kaatz M, Utikal J, Göppner D, Pföhler C, Pflugfelder A, Mössner R, Gutzmer R; Dermatologic Cooperative Oncology Group (DeCOG)(2015)
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival.
Ann Oncol 26, 573-82.

Vaman V S A, Poppe H, Houben R, Grunewald TG, Goebeler M, Butt E(2015)
LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.
PLoS One 10:e0129219.

Wobser M, Bauer B, Goebeler M (2015)
Subcutaneous nodule on the scrotum.
J Dtsch Dermatol Ges 13, 165-7.

Wobser M, Ernestus K, Hamm H (2015)
Pediatric dermatohistopathology - histopathology of skin diseases in newborns and infants.
J Dtsch Dermatol Ges 13, 535-48.

Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E (2015)
CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
Br J Dermatol 172, 1573-80.

Zeller S, Lempert S, Goebeler M, Hamm H, Kolb-Mäurer A (2015)
Cladosporium cladosporioides: a so far unidentified cause of white piedra.
Mycoses 58, 315-7.

Zörnig I, Halama N, Lorenzo Bermejo J, Ziegelmeier C, Dickes E, Migdoll A, Kaiser I, Waterboer T, Pawlita M, Grabe N, Ugurel S, Schadendorf D, Falk C, Eichmüller SB, Jäger D (2015)
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.
Int J Cancer 136, 138-5.

Publikationen 2014

Adam C, Baeurle A, Brodsky JL, Wipf P, Schrama D, Becker JC, Houben R (2014)
The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma.
PLoS ONE 9:e92041.

Aigner B, Ugurel S, Kaddu S, Becker JC. Kutane Sarkome (2014)
Update ausgewählter Entitäten fibrohistiozytärer und myofibrozytärer Morphologie.
Hautarzt 65, 614-622.

Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R (2014)
Response to Shuda et al.
J Invest Dermatol 134, 1481-2.

Behle V, Hamm H (2014)
Developmental abnormalities and nevi of the scalp.
Hautarzt 65, 1022-9.

Behr DS, Peitsch WK, Hametner C, Lasitschka F, Houben R, Schönhaar K, Michel J, Dollt C, Goebeler M, Marx A, Goerdt S, Schmieder A (2014)
Prognostic value of immune cell infiltration, tertiary lymphoid structures and pd-l1 expression in Merkel cell carcinomas.
Int J Clin Exp Pathol 7, 7610-21.

Benoit S, Goebeler M (2014)
Vasculitis in childhood - a dermatological approach.
J Dtsch Dermatol Ges 12, 124-9.

Benoit S, Schlipf N, Hausser I, Fischer J, Hamm H (2014)
White Sponge Nevus - A Rare Autosomal Dominant Keratinopathy.
Klin Padiatr 226, 375-376.

Brasch J, Becker D, Aberer W, Bircher A, Kränke B, Jung K, Przybilla B, Biedermann T, Werfel T, John SM, Elsner P, Diepgen T, Trautmann A, Merk HF, Fuchs T, Schnuch A (2014)
Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG.
Allergo J Int 23, 126-138.

Buder K, Hamm H (2014)
Residents' corner October 2014. Nail it! A bleeding tumour at the fingertip.
Eur J Dermatol 24, 637-8.

Buder K, Hamm H. Residents' corner April 2014 (2014)
Nail it!: eye-catching nail folds.
Eur J Dermatol 24, 283-4.

Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JCn(2014)
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.
BMC Cancer 14, 268.

Buder K, Ruppert S, Trautmann A, Bröcker E-B, Goebeler M, Kerstan A (2014) Angiolymphoide Hyperplasie mit Eosinophilie und Morbus Kimura - ein klinischer und histopathologischer Vergleich.
J Dtsch Dermatol Ges 12, 224-8.

Buder K, Müller PA, Beckmann G, Ugurel S, Bröcker EB, Becker JC (2014)
Denileukin Diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell lymphoma (Mycosis fungoides): report of four cases.
Acta Derm Venereol 94, 94-96.

Chandran PA, Keller A, Weinmann L, Seida AA, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J (2014)
The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺T cells.
J Leukoc Biol 96, 633-45.

Fredholm S, Gjerdrum LM, Willerslev-Olsen A, Petersen DL, Nielsen IØ, Kauczok CS, Wobser M, Ralfkiaer U, Bonefeld CM, Wasik MA, Krejsgaard T, Geisler C, Ralfkiaer E, Gniadecki R, Woetmann A, Odum N (2014)
STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides. Anticancer Res 34, 5277-86.

Gerstner S, Kneitz H, Bröcker EB, Trautmann A (2014)
Differentialdiagnose Angioödem. Akut ödematöses Skleromyxödem.
Hautarzt 65, 454-7.

Goldinger SM, Zimmer L, Schulz C, Ugurel S, Hoeller C, Kaehler KC, Schadendorf D, Hassel JC, Becker J, Hauschild A, Dummer R; Dermatology Cooperative Oncology Group (DeCOG) (2014)
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients.
Eur J Cancer 50, 406-10.

Gutzmer R, Hassel JC, Kähler KC, Loquai C, Mössner R, Ugurel S, Zimmer L, für das Komitee "Kutane Nebenwirkungen" der ADO (2014)
Kutane Nebenwirkungen der medikamentösen Tumortherapie mit BRAF- und MEK-Inhibitoren.
Hautarzt 65, 582-89.

Hamm H, Wolff H (2014)
Blickpunkt Kopfhaut.
Hautarzt 65, 1020-1.

Hamm, H (2014)
Impact of Hyperhidrosis on Quality of Life and its Assessment.
Dermatol Clin 32, 467-76.

Havlickova B, Weyandt GH (2014)
Therapeutic management of anal eczema: an evidence-based review.
Int J Clin Pract 68, 1388-99.

Heiduschka G, Lill C, Seemann R, Brunner M, Schmid R, Houben R, Bigenzahn J, Thurnher D (2014)
The effect of resveratrol in combination with irradiation and chemotherapy.
Strahlenther Onkol 190, 75-80.

Höger PH, Hamm H (2014)
Psoriasis vulgaris bei Kinder und Jugendlichen.
Monatsschr Kinderheilkd 162, 163-77.

Houben R, Schmid CP, Maier M, Wobser M, Motschenbacher S, Becker JC, Vetter-Kauczok CS, Weyandt G, Hesbacher S, Haferkamp S (2014)
p53 Regulation by TRP2 Is Not Pervasive in Melanoma.
PLoS ONE 9:e87440.

Humbert P, Faivre B, Véran Y, Debure C, Truchetet F, Bécherel PA, Plantin P, Kerihuel JC, Eming SA, Dissemond J, Weyandt G, Kaspar D, Smola H, Zöllner P, the CLEANSITE study group (2014)
Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers - a randomized controlled trial.
J Eur Acad Dermatol Venereol 28, 1742-50.

Karademir F, Kerstan A, Hamm H (2014)
Anetodermisches Pilomatrikom. Seltene Variante eines häufigen Adnextumors im Kindesalter.
Hautarzt 65, 59-62.

Karl I, Jossberger-Werner M, Schmidt N, Horn S, Goebeler M, Leverkus M, Wajant H, Giner T (2014)
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis.
Cell Death Dis 5:e1444.

Kolb-Mäurer A, Betz RC, Hamm H (2014)
Odd-Looking Hair and Progressive Alopecia in Mother and Son.
JAMA Dermatol 150, 567-8.

Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G; The EUSCLE Co-Authors (u. a. Benoit S, Bröcker E) (2014)
Influence of Smoking on Disease Severity and Antimalarial Therapy in Cutaneous Lupus Erythematosus: Analysis of 1002 Patients from the EUSCLE Database.
Br J Dermatol 171, 571-9.

Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-Grez, Böhm-Steuer B, Bröcker E-B, Mauch C, Utikal J, Hartschuh W, Purdie KJ, Boukamp P (2014)
The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
Oncogene 33, 3506-18.

Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT, Seo A, Koelle DM, Madeleine MM, Bhatia S, Nakajima H, Sano S, Hardwick J, Disis ML, Cleary MA, Becker JC, Nghiem P (2014)
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Cancer Immunol Res 2, 1071-9.

Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC (2014)
Presence of Human Polyomavirus 6 in Mutation-Specific BRAF Inhibitor-Induced Epithelial Proliferations.
JAMA Dermatol 150, 1180-6.

Schrama D, Ugurel S, Sucker A, Ritter C, Zapatka M, Schadendorf D, Becker JC (2014)
STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients.
Front Med (Lausanne) 1, 47.

Seitz CS, Brockow K, Hain J, Trautmann A (2014)
Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?
Allergy Asthma Clin Immunol 10, 19.

Starke J, Wehrle-Haller B, Friedl P (2014)
Plasticity of the actin cytoskeleton in response to extracellular matrix nanostructure and dimensionality.
Biochem Soc Trans. 42, 1356-66.

Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A (2014)
Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy buildup phase.
Clin Exp Allergy 44, 747-55.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A (2014)
Risikostratifizierung systemischer allergischer Reaktionen während Einleitung der spezifischen Immuntherapie mit Bienen- und Wespengift.
J Dtsch Dermatol Ges 12, 244-56.

Trautmann A, Seitz CS, Stoevesandt J, Kerstan A (2014)
Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited.
Clin Exp Allergy 44, 1531-8.

Ugurel S, Mentzel T, Utikal J, Helmbold P, Mohr P, Pföhler C, Schiller M, Hauschild A, Hein R, Kämpgen E, Kellner I, Leverkus M, Becker JC, Ströbel P, Schadendorf D (2014)
Neo-adjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase-II DeCOG trial with long-term follow-up.
Clin Cancer Res 20, 499-510.

Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, Hodis E, Rosenberg M, McKenna A, Cibulskis K, Farlow D, Zimmer L, Hillen U, Gutzmer R, Goldinger SM, Ugurel S, Gogas HJ, Egberts F, Berking C, Trefzer U, Loquai C, Weide B, Hassel JC, Gabriel SB, Carter SL, Getz G, Garraway LA, Schadendorf D; Dermatologic Cooperative Oncology Group of Germany (DeCOG) (2014)
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma.
Cancer Discov 4, 94-109.

Waldenburger S, Vogel U, Goebeler M, Kolb-Mäurer A (2014)
Ambulant erworbene Hautinfektionen durch Staphylococcus aureus: spielt das Toxin Panton-Valentine-Leukozidin eine Rolle?
J Dtsch Dermatol Ges 12:59-67.

Weishaupt J, Kolb-Mäurer A, Lempert S, Nenoff P, Uhrlaß S, Hamm H, Goebeler M (2014)
A different kind of hedgehog pathway: tinea manus due to Trichophyton erinacei transmitted by an African pygmy hedgehog (Atelerix albiventris).
Mycoses 57, 125-7.

Wieshuber C, Stoevesandt J, Trautmann A (2014)
The needle in the haystack: allergic anaphylaxis caused by the local anesthetic articaine.
Eur Ann Allergy Clin Immunol 46, 38-40.

Wobser M, Hamm H (2014)
Teleangiectasia macularis eruptiva perstans with congenital onset in a 5-year-old girl.
Clin Dermatol 2:144-146.

Kontakt, Öffnungszeiten, Sprechzeiten

Terminvereinbarung Poliklinik

Tel. +49 931 201-26714

Montag bis Donnerstag
08:00 Uhr bis 10:00 Uhr und
13:00 Uhr bis 16:00 Uhr

Freitag
08:00 Uhr bis 10:00 Uhr und
13:00 Uhr bis 15:00 Uhr

Terminvereinbarung Privatambulanz

Montag bis Freitag
08:00 Uhr bis 12:00 Uhr

Margit Körner
Tel. +49 931 201-26354

Telefon

Pforte
+49 931 201-26710

Direktor
Prof. Dr. med. Matthias Goebeler

Sekretariat
Gudrun Braun
+49 931 201-26351

Studierendenangelegenheiten
Ute Düchs
+49 931 201-26353

E-Mail

info-hautklinik@ ukw.de

Fax

+49 931 201-26700


Anschrift

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie | Josef-Schneider-Straße 2 | Haus D8 | 97080 Würzburg | Deutschland